JPS6314707A - External preparation for skin - Google Patents
External preparation for skinInfo
- Publication number
- JPS6314707A JPS6314707A JP61160189A JP16018986A JPS6314707A JP S6314707 A JPS6314707 A JP S6314707A JP 61160189 A JP61160189 A JP 61160189A JP 16018986 A JP16018986 A JP 16018986A JP S6314707 A JPS6314707 A JP S6314707A
- Authority
- JP
- Japan
- Prior art keywords
- tropoelastin
- acid
- ether
- skin
- poe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 108010014258 Elastin Proteins 0.000 claims abstract description 109
- 102100033167 Elastin Human genes 0.000 claims abstract description 87
- 239000002299 complementary DNA Substances 0.000 claims abstract description 31
- 241000588724 Escherichia coli Species 0.000 claims abstract description 19
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 13
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 13
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 13
- 241000282414 Homo sapiens Species 0.000 claims abstract description 11
- 241000287828 Gallus gallus Species 0.000 claims abstract description 6
- 108020004999 messenger RNA Proteins 0.000 claims abstract description 6
- 241000283690 Bos taurus Species 0.000 claims abstract description 4
- 241000282898 Sus scrofa Species 0.000 claims abstract 2
- 239000013604 expression vector Substances 0.000 claims description 27
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 2
- 241001494479 Pecora Species 0.000 claims description 2
- 102000016942 Elastin Human genes 0.000 abstract description 22
- 229920002549 elastin Polymers 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 14
- 108090000623 proteins and genes Proteins 0.000 abstract description 14
- 239000013598 vector Substances 0.000 abstract description 13
- 239000003814 drug Substances 0.000 abstract description 7
- 210000000709 aorta Anatomy 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 5
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 239000002537 cosmetic Substances 0.000 abstract description 4
- 238000010353 genetic engineering Methods 0.000 abstract description 3
- 239000002243 precursor Substances 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 2
- 206010040849 Skin fissures Diseases 0.000 abstract 1
- -1 cetyl octoate Chemical compound 0.000 description 73
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 72
- 239000004615 ingredient Substances 0.000 description 66
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 57
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 51
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 49
- 239000008213 purified water Substances 0.000 description 42
- 239000012071 phase Substances 0.000 description 40
- 239000003205 fragrance Substances 0.000 description 36
- 238000003756 stirring Methods 0.000 description 35
- 238000000034 method Methods 0.000 description 34
- 235000019441 ethanol Nutrition 0.000 description 33
- 239000003795 chemical substances by application Substances 0.000 description 32
- 210000003491 skin Anatomy 0.000 description 28
- 235000014113 dietary fatty acids Nutrition 0.000 description 26
- 229930195729 fatty acid Natural products 0.000 description 26
- 239000000194 fatty acid Substances 0.000 description 26
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 25
- 239000003921 oil Substances 0.000 description 24
- 235000019198 oils Nutrition 0.000 description 24
- 239000006210 lotion Substances 0.000 description 20
- 238000004519 manufacturing process Methods 0.000 description 20
- 150000001413 amino acids Chemical class 0.000 description 19
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 18
- 229960004063 propylene glycol Drugs 0.000 description 18
- 239000011734 sodium Substances 0.000 description 17
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 16
- 229910052708 sodium Inorganic materials 0.000 description 16
- 108020004414 DNA Proteins 0.000 description 15
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 15
- 239000002253 acid Substances 0.000 description 15
- 239000002609 medium Substances 0.000 description 15
- 239000013612 plasmid Substances 0.000 description 15
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 14
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 14
- 239000004166 Lanolin Substances 0.000 description 14
- 235000011187 glycerol Nutrition 0.000 description 14
- 229960005150 glycerol Drugs 0.000 description 14
- 235000019388 lanolin Nutrition 0.000 description 14
- 229940039717 lanolin Drugs 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 13
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 13
- 239000012634 fragment Substances 0.000 description 13
- 150000004665 fatty acids Chemical class 0.000 description 12
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 11
- 239000002585 base Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 10
- 239000004359 castor oil Substances 0.000 description 10
- 235000019438 castor oil Nutrition 0.000 description 10
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 10
- 239000001993 wax Substances 0.000 description 10
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 9
- 239000002202 Polyethylene glycol Substances 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 8
- 229960000723 ampicillin Drugs 0.000 description 8
- 235000019864 coconut oil Nutrition 0.000 description 8
- 239000003240 coconut oil Substances 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 8
- 229920001223 polyethylene glycol Polymers 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 229940034610 toothpaste Drugs 0.000 description 8
- 239000000606 toothpaste Substances 0.000 description 8
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 7
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 7
- 239000006096 absorbing agent Substances 0.000 description 7
- 235000011114 ammonium hydroxide Nutrition 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- 238000007796 conventional method Methods 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 7
- 239000003755 preservative agent Substances 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 210000004761 scalp Anatomy 0.000 description 7
- 239000000344 soap Substances 0.000 description 7
- 229960002920 sorbitol Drugs 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- 206010013786 Dry skin Diseases 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 6
- 229920001214 Polysorbate 60 Polymers 0.000 description 6
- 108010076504 Protein Sorting Signals Proteins 0.000 description 6
- 235000021355 Stearic acid Nutrition 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 229960000541 cetyl alcohol Drugs 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000010367 cloning Methods 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 230000002335 preservative effect Effects 0.000 description 6
- 239000008117 stearic acid Substances 0.000 description 6
- 239000003760 tallow Substances 0.000 description 6
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 description 5
- 235000004443 Ricinus communis Nutrition 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 206010042496 Sunburn Diseases 0.000 description 5
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 description 5
- 235000010216 calcium carbonate Nutrition 0.000 description 5
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 5
- 230000001815 facial effect Effects 0.000 description 5
- 238000005342 ion exchange Methods 0.000 description 5
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 5
- 229940057995 liquid paraffin Drugs 0.000 description 5
- 239000010445 mica Substances 0.000 description 5
- 229910052618 mica group Inorganic materials 0.000 description 5
- 208000028169 periodontal disease Diseases 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 5
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 5
- 239000001593 sorbitan monooleate Substances 0.000 description 5
- 229940035049 sorbitan monooleate Drugs 0.000 description 5
- 239000000600 sorbitol Substances 0.000 description 5
- 235000010356 sorbitol Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 5
- 239000004408 titanium dioxide Substances 0.000 description 5
- 235000010215 titanium dioxide Nutrition 0.000 description 5
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 4
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 4
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- 239000005995 Aluminium silicate Substances 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 235000017788 Cydonia oblonga Nutrition 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 4
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 235000012211 aluminium silicate Nutrition 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 235000013330 chicken meat Nutrition 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 4
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 4
- 229940075507 glyceryl monostearate Drugs 0.000 description 4
- 239000000118 hair dye Substances 0.000 description 4
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 4
- 125000005647 linker group Chemical group 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 235000011118 potassium hydroxide Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 235000011069 sorbitan monooleate Nutrition 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- 235000012222 talc Nutrition 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 229940099259 vaseline Drugs 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- 239000011787 zinc oxide Substances 0.000 description 4
- 235000014692 zinc oxide Nutrition 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 239000004925 Acrylic resin Substances 0.000 description 3
- 229920000178 Acrylic resin Polymers 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 3
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 102000011632 Caseins Human genes 0.000 description 3
- 108010076119 Caseins Proteins 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 3
- 108010061982 DNA Ligases Proteins 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- 102100031780 Endonuclease Human genes 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 229920000161 Locust bean gum Polymers 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229960003767 alanine Drugs 0.000 description 3
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 3
- 239000001099 ammonium carbonate Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 239000000440 bentonite Substances 0.000 description 3
- 229910000278 bentonite Inorganic materials 0.000 description 3
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 3
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-aminopropionic acid Natural products NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 229960000846 camphor Drugs 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 210000003298 dental enamel Anatomy 0.000 description 3
- 239000005546 dideoxynucleotide Substances 0.000 description 3
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 3
- 229940043264 dodecyl sulfate Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000012869 ethanol precipitation Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 3
- 229910000271 hectorite Inorganic materials 0.000 description 3
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 3
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 229940094522 laponite Drugs 0.000 description 3
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 3
- 235000010420 locust bean gum Nutrition 0.000 description 3
- 239000000711 locust bean gum Substances 0.000 description 3
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920000120 polyethyl acrylate Polymers 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 239000001587 sorbitan monostearate Substances 0.000 description 3
- 229940035048 sorbitan monostearate Drugs 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 3
- 239000012137 tryptone Substances 0.000 description 3
- 238000004804 winding Methods 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- VEVRNHHLCPGNDU-MUGJNUQGSA-N (2s)-2-amino-5-[1-[(5s)-5-amino-5-carboxypentyl]-3,5-bis[(3s)-3-amino-3-carboxypropyl]pyridin-1-ium-4-yl]pentanoate Chemical compound OC(=O)[C@@H](N)CCCC[N+]1=CC(CC[C@H](N)C(O)=O)=C(CCC[C@H](N)C([O-])=O)C(CC[C@H](N)C(O)=O)=C1 VEVRNHHLCPGNDU-MUGJNUQGSA-N 0.000 description 2
- HYLBTMZBXLEVCL-UWVGGRQHSA-N (2s)-2-amino-6-[[(5s)-5-amino-5-carboxypentyl]amino]hexanoic acid Chemical compound OC(=O)[C@@H](N)CCCCNCCCC[C@H](N)C(O)=O HYLBTMZBXLEVCL-UWVGGRQHSA-N 0.000 description 2
- LSJKARAMQNGZDF-YOEKFXIASA-N (4as,4br,10bs,12as)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate Chemical compound C([C@H]1[C@H]2[C@@H](C3=CC=C(OS(N)(=O)=O)C=C3CC2)CC[C@@]1(C1=O)C)C(=O)N1CC1=CC=CN=C1 LSJKARAMQNGZDF-YOEKFXIASA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 2
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 2
- XLLIQLLCWZCATF-UHFFFAOYSA-N 2-methoxyethyl acetate Chemical compound COCCOC(C)=O XLLIQLLCWZCATF-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- 241000304886 Bacilli Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 229920000569 Gum karaya Polymers 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- 241000039951 Lithocarpus glaber Species 0.000 description 2
- 244000280244 Luffa acutangula Species 0.000 description 2
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229940000635 beta-alanine Drugs 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229940073609 bismuth oxychloride Drugs 0.000 description 2
- 230000001680 brushing effect Effects 0.000 description 2
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 239000004204 candelilla wax Substances 0.000 description 2
- 235000013868 candelilla wax Nutrition 0.000 description 2
- 229940073532 candelilla wax Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 229920006317 cationic polymer Polymers 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 2
- 229910000423 chromium oxide Inorganic materials 0.000 description 2
- 239000002734 clay mineral Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000003766 combability Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- 238000002298 density-gradient ultracentrifugation Methods 0.000 description 2
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 2
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 229940009662 edetate Drugs 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 239000008266 hair spray Substances 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 229960002591 hydroxyproline Drugs 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- LDHBWEYLDHLIBQ-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide;hydrate Chemical compound O.[OH-].[O-2].[Fe+3] LDHBWEYLDHLIBQ-UHFFFAOYSA-M 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- RGXCTRIQQODGIZ-UHFFFAOYSA-O isodesmosine Chemical compound OC(=O)C(N)CCCC[N+]1=CC(CCC(N)C(O)=O)=CC(CCC(N)C(O)=O)=C1CCCC(N)C(O)=O RGXCTRIQQODGIZ-UHFFFAOYSA-O 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 235000010494 karaya gum Nutrition 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 108010057846 lysinenorleucine Proteins 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N o-aminobenzenecarboxylic acid Natural products NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 2
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229960000969 phenyl salicylate Drugs 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 2
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920002689 polyvinyl acetate Polymers 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000001651 pyrus cydonia seed extract Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229940085605 saccharin sodium Drugs 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- XUXNAKZDHHEHPC-UHFFFAOYSA-M sodium bromate Chemical compound [Na+].[O-]Br(=O)=O XUXNAKZDHHEHPC-UHFFFAOYSA-M 0.000 description 2
- 229940037001 sodium edetate Drugs 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 2
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- CSUUDNFYSFENAE-UHFFFAOYSA-N (2-methoxyphenyl)-phenylmethanone Chemical compound COC1=CC=CC=C1C(=O)C1=CC=CC=C1 CSUUDNFYSFENAE-UHFFFAOYSA-N 0.000 description 1
- SGWFGVQCRDTUQN-UHFFFAOYSA-N (2-prop-2-ynoyloxy-3-prop-2-ynoylsulfanylpropyl) prop-2-ynoate Chemical compound C#CC(=O)OCC(OC(=O)C#C)CSC(=O)C#C SGWFGVQCRDTUQN-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 1
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- CUVLMZNMSPJDON-UHFFFAOYSA-N 1-(1-butoxypropan-2-yloxy)propan-2-ol Chemical compound CCCCOCC(C)OCC(C)O CUVLMZNMSPJDON-UHFFFAOYSA-N 0.000 description 1
- GDXHBFHOEYVPED-UHFFFAOYSA-N 1-(2-butoxyethoxy)butane Chemical compound CCCCOCCOCCCC GDXHBFHOEYVPED-UHFFFAOYSA-N 0.000 description 1
- DXMNMEWATKSWOT-UHFFFAOYSA-N 1-[2,3-di(nonyl)phenoxy]-2,3-di(nonyl)benzene Chemical compound CCCCCCCCCC1=CC=CC(OC=2C(=C(CCCCCCCCC)C=CC=2)CCCCCCCCC)=C1CCCCCCCCC DXMNMEWATKSWOT-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- ZXNAIPHYBVMMPY-KTKRTIGZSA-N 1-erucoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCC(O)CO ZXNAIPHYBVMMPY-KTKRTIGZSA-N 0.000 description 1
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- CNJRPYFBORAQAU-UHFFFAOYSA-N 1-ethoxy-2-(2-methoxyethoxy)ethane Chemical compound CCOCCOCCOC CNJRPYFBORAQAU-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- LIPRQQHINVWJCH-UHFFFAOYSA-N 1-ethoxypropan-2-yl acetate Chemical compound CCOCC(C)OC(C)=O LIPRQQHINVWJCH-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- LCCCAFOMMQBWHG-UHFFFAOYSA-N 1-methylidenepiperidin-1-ium Chemical compound C=[N+]1CCCCC1 LCCCAFOMMQBWHG-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- JWKSQNWLEIABLH-UHFFFAOYSA-N 1-octan-2-yloxydodecane Chemical compound CCCCCCCCCCCCOC(C)CCCCCC JWKSQNWLEIABLH-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- QWWTXMUURQLKOT-UHFFFAOYSA-N 1-phenoxypropan-2-yl acetate Chemical compound CC(=O)OC(C)COC1=CC=CC=C1 QWWTXMUURQLKOT-UHFFFAOYSA-N 0.000 description 1
- QQXJNLYVPPBERR-UHFFFAOYSA-N 1-phenyldecan-1-one Chemical compound CCCCCCCCCC(=O)C1=CC=CC=C1 QQXJNLYVPPBERR-UHFFFAOYSA-N 0.000 description 1
- DMFAHCVITRDZQB-UHFFFAOYSA-N 1-propoxypropan-2-yl acetate Chemical compound CCCOCC(C)OC(C)=O DMFAHCVITRDZQB-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GQQNRZHWHWHOLI-UHFFFAOYSA-N 11-(2-decyltetradecoxymethyl)tricosane Chemical compound CCCCCCCCCCCCC(CCCCCCCCCC)COCC(CCCCCCCCCC)CCCCCCCCCCCC GQQNRZHWHWHOLI-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- XWZPJRNVELUELY-GDVGLLTNSA-N 2,3-dihydroxypropyl (2s)-5-oxopyrrolidine-2-carboxylate Chemical compound OCC(O)COC(=O)[C@@H]1CCC(=O)N1 XWZPJRNVELUELY-GDVGLLTNSA-N 0.000 description 1
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 1
- MTVLEKBQSDTQGO-UHFFFAOYSA-N 2-(2-ethoxypropoxy)propan-1-ol Chemical compound CCOC(C)COC(C)CO MTVLEKBQSDTQGO-UHFFFAOYSA-N 0.000 description 1
- KCZIRQGMWBGPRP-UHFFFAOYSA-N 2-(2-hydroxyacetyl)oxyethyl 2-hydroxyacetate Chemical compound OCC(=O)OCCOC(=O)CO KCZIRQGMWBGPRP-UHFFFAOYSA-N 0.000 description 1
- CUDYYMUUJHLCGZ-UHFFFAOYSA-N 2-(2-methoxypropoxy)propan-1-ol Chemical compound COC(C)COC(C)CO CUDYYMUUJHLCGZ-UHFFFAOYSA-N 0.000 description 1
- FEVQEKNYIKQVIR-UHFFFAOYSA-N 2-(2-methylhexoxy)ethanol Chemical compound CCCCC(C)COCCO FEVQEKNYIKQVIR-UHFFFAOYSA-N 0.000 description 1
- NCHBYORVPVDWBJ-UHFFFAOYSA-N 2-(3-methylbutoxy)ethanol Chemical compound CC(C)CCOCCO NCHBYORVPVDWBJ-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- AVBJHQDHVYGQLS-UHFFFAOYSA-N 2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-UHFFFAOYSA-N 0.000 description 1
- VBCKYDVWOPZOBA-UHFFFAOYSA-N 2-(oxolan-2-ylmethoxymethyl)oxolane Chemical compound C1CCOC1COCC1CCCO1 VBCKYDVWOPZOBA-UHFFFAOYSA-N 0.000 description 1
- RWLALWYNXFYRGW-UHFFFAOYSA-N 2-Ethyl-1,3-hexanediol Chemical compound CCCC(O)C(CC)CO RWLALWYNXFYRGW-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- WFSMVVDJSNMRAR-UHFFFAOYSA-N 2-[2-(2-ethoxyethoxy)ethoxy]ethanol Chemical compound CCOCCOCCOCCO WFSMVVDJSNMRAR-UHFFFAOYSA-N 0.000 description 1
- WFIYPADYPQQLNN-UHFFFAOYSA-N 2-[2-(4-bromopyrazol-1-yl)ethyl]isoindole-1,3-dione Chemical compound C1=C(Br)C=NN1CCN1C(=O)C2=CC=CC=C2C1=O WFIYPADYPQQLNN-UHFFFAOYSA-N 0.000 description 1
- LNCJHVLXANMHHD-UHFFFAOYSA-N 2-[2-heptadecyl-1-(2-hydroxyethyl)-4,5-dihydroimidazol-1-ium-1-yl]acetate Chemical compound CCCCCCCCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O LNCJHVLXANMHHD-UHFFFAOYSA-N 0.000 description 1
- BTMZHHCFEOXAAN-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;2-dodecylbenzenesulfonic acid Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O BTMZHHCFEOXAAN-UHFFFAOYSA-N 0.000 description 1
- ZCOLQXXFCPFSNU-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]ethanesulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O ZCOLQXXFCPFSNU-UHFFFAOYSA-N 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- LHASZEBEQGPCFM-CJFMBICVSA-N 2-amino-4-[(1r)-1-[[(6r)-6-[(5-chloro-2-methoxyphenyl)methyl]-7-oxo-3-(phenoxyamino)-5,6-dihydro-2h-1,4-diazepine-1-carbonyl]amino]propyl]benzoic acid Chemical compound C([C@@H]1CNC(CN(C1=O)C(=O)N[C@H](CC)C=1C=C(N)C(C(O)=O)=CC=1)=NOC=1C=CC=CC=1)C1=CC(Cl)=CC=C1OC LHASZEBEQGPCFM-CJFMBICVSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- NQBXSWAWVZHKBZ-UHFFFAOYSA-N 2-butoxyethyl acetate Chemical compound CCCCOCCOC(C)=O NQBXSWAWVZHKBZ-UHFFFAOYSA-N 0.000 description 1
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- WBIQQQGBSDOWNP-UHFFFAOYSA-N 2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O WBIQQQGBSDOWNP-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- SVONRAPFKPVNKG-UHFFFAOYSA-N 2-ethoxyethyl acetate Chemical compound CCOCCOC(C)=O SVONRAPFKPVNKG-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- OQUFOZNPBIIJTN-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;sodium Chemical compound [Na].OC(=O)CC(O)(C(O)=O)CC(O)=O OQUFOZNPBIIJTN-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- WHFKYDMBUMLWDA-UHFFFAOYSA-N 2-phenoxyethyl acetate Chemical compound CC(=O)OCCOC1=CC=CC=C1 WHFKYDMBUMLWDA-UHFFFAOYSA-N 0.000 description 1
- CUZKCNWZBXLAJX-UHFFFAOYSA-N 2-phenylmethoxyethanol Chemical compound OCCOCC1=CC=CC=C1 CUZKCNWZBXLAJX-UHFFFAOYSA-N 0.000 description 1
- HCGFUIQPSOCUHI-UHFFFAOYSA-N 2-propan-2-yloxyethanol Chemical compound CC(C)OCCO HCGFUIQPSOCUHI-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- BKTMEKOLXCZRFW-UHFFFAOYSA-N 3-(octadecylamino)propanoic acid Chemical compound CCCCCCCCCCCCCCCCCCNCCC(O)=O BKTMEKOLXCZRFW-UHFFFAOYSA-N 0.000 description 1
- CWLKGDAVCFYWJK-UHFFFAOYSA-N 3-aminophenol Chemical compound NC1=CC=CC(O)=C1 CWLKGDAVCFYWJK-UHFFFAOYSA-N 0.000 description 1
- GBSGXZBOFKJGMG-UHFFFAOYSA-N 3-propan-2-yloxypropan-1-ol Chemical compound CC(C)OCCCO GBSGXZBOFKJGMG-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- FBMWYZZRSWZLDZ-UHFFFAOYSA-N 4,5-dihydro-1h-imidazol-1-ium;hydroxide Chemical compound O.C1CN=CN1 FBMWYZZRSWZLDZ-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- WMNORUTYNGVDKW-UHFFFAOYSA-N 4-ethyl-2-[(4-methoxyphenyl)methylidene]octanoic acid;octyl 3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=C(OC)C=C1.CCCCC(CC)CC(C(O)=O)=CC1=CC=C(OC)C=C1 WMNORUTYNGVDKW-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- RDBLNMQDEWOUIB-UHFFFAOYSA-N 5-methyl-2-phenyl-1,3-benzoxazole Chemical compound N=1C2=CC(C)=CC=C2OC=1C1=CC=CC=C1 RDBLNMQDEWOUIB-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- ZGOIAORBAXGMCW-UHFFFAOYSA-N CCC.C(CCCCCCCCCCCCCCC(C)C)(=O)OCO.C(CCCCCCCCCCCCCCC(C)C)(=O)OCO.C(CCCCCCCCCCCCCCC(C)C)(=O)OCO Chemical compound CCC.C(CCCCCCCCCCCCCCC(C)C)(=O)OCO.C(CCCCCCCCCCCCCCC(C)C)(=O)OCO.C(CCCCCCCCCCCCCCC(C)C)(=O)OCO ZGOIAORBAXGMCW-UHFFFAOYSA-N 0.000 description 1
- 101100328086 Caenorhabditis elegans cla-1 gene Proteins 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
- 102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102100039555 Galectin-7 Human genes 0.000 description 1
- 101000851055 Gallus gallus Elastin Proteins 0.000 description 1
- 101000887163 Gallus gallus Gallinacin-4 Proteins 0.000 description 1
- 101000887166 Gallus gallus Gallinacin-7 Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 239000004169 Hydrogenated Poly-1-Decene Substances 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000735234 Ligustrum Species 0.000 description 1
- 108091036060 Linker DNA Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 244000131360 Morinda citrifolia Species 0.000 description 1
- 101100272224 Mus musculus Bcam gene Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 241000282337 Nasua nasua Species 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 101710167911 Repressible acid phosphatase Proteins 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010070835 Skin sensitisation Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 239000004163 Spermaceti wax Substances 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- WFWLQNSHRPWKFK-UHFFFAOYSA-N Tegafur Chemical compound O=C1NC(=O)C(F)=CN1C1OCCC1 WFWLQNSHRPWKFK-UHFFFAOYSA-N 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N Tetraethylene glycol, Natural products OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 108010082433 UDP-glucose-hexose-1-phosphate uridylyltransferase Proteins 0.000 description 1
- IOUPEELXVYPCPG-UHFFFAOYSA-N Valylglycine Chemical compound CC(C)C(N)C(=O)NCC(O)=O IOUPEELXVYPCPG-UHFFFAOYSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- WERKSKAQRVDLDW-ANOHMWSOSA-N [(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO WERKSKAQRVDLDW-ANOHMWSOSA-N 0.000 description 1
- LDDUCKDUDZVHLN-UHFFFAOYSA-N [2-hydroxy-3-[2-hydroxy-3-(16-methylheptadecanoyloxy)propoxy]propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCCCCCCCCCCCCCC(C)C LDDUCKDUDZVHLN-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- NUUGVTRRUDKBOZ-UHFFFAOYSA-N acetyl 2-aminobenzoate Chemical compound CC(=O)OC(=O)C1=CC=CC=C1N NUUGVTRRUDKBOZ-UHFFFAOYSA-N 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229920000180 alkyd Polymers 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- ZZTCCAPMZLDHFM-UHFFFAOYSA-N ammonium thioglycolate Chemical compound [NH4+].[O-]C(=O)CS ZZTCCAPMZLDHFM-UHFFFAOYSA-N 0.000 description 1
- 229940075861 ammonium thioglycolate Drugs 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- BJFLSHMHTPAZHO-UHFFFAOYSA-N benzotriazole Chemical compound [CH]1C=CC=C2N=NN=C21 BJFLSHMHTPAZHO-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- UGDWJDYCTNYZEU-UHFFFAOYSA-N butanedioic acid;ethane-1,2-diol Chemical compound OCCO.OC(=O)CCC(O)=O.OC(=O)CCC(O)=O UGDWJDYCTNYZEU-UHFFFAOYSA-N 0.000 description 1
- IAQRGUVFOMOMEM-UHFFFAOYSA-N butene Natural products CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 1
- 229940105847 calamine Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000019383 crystalline wax Nutrition 0.000 description 1
- WANLJGSQMHAZLK-UHFFFAOYSA-N cyano 3,3-diphenylprop-2-enoate Chemical compound C=1C=CC=CC=1C(=CC(OC#N)=O)C1=CC=CC=C1 WANLJGSQMHAZLK-UHFFFAOYSA-N 0.000 description 1
- FGEUKKGODAGXOD-FMIVXFBMSA-N cyclohexyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound C1=CC(OC)=CC=C1\C=C\C(=O)OC1CCCCC1 FGEUKKGODAGXOD-FMIVXFBMSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- NLITVVBCKVLFMM-UHFFFAOYSA-N diazanium;2-(2-oxido-2-sulfanylideneethoxy)ethanethioate Chemical compound [NH4+].[NH4+].[O-]C(=S)COCC([O-])=S NLITVVBCKVLFMM-UHFFFAOYSA-N 0.000 description 1
- 229940111685 dibasic potassium phosphate Drugs 0.000 description 1
- 229940061607 dibasic sodium phosphate Drugs 0.000 description 1
- OLSDWRNWUGHKSY-UHFFFAOYSA-J dicalcium;phosphonato phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O OLSDWRNWUGHKSY-UHFFFAOYSA-J 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- FSBVERYRVPGNGG-UHFFFAOYSA-N dimagnesium dioxido-bis[[oxido(oxo)silyl]oxy]silane hydrate Chemical compound O.[Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O FSBVERYRVPGNGG-UHFFFAOYSA-N 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- OGGBYDPEZJVNHM-UHFFFAOYSA-N dodecanoate;hydron;potassium Chemical compound [K].CCCCCCCCCCCC(O)=O OGGBYDPEZJVNHM-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- JZKFHQMONDVVNF-UHFFFAOYSA-N dodecyl sulfate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(O)(=O)=O JZKFHQMONDVVNF-UHFFFAOYSA-N 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- XRLCQRMNGQRGOC-MDZDMXLPSA-N ethyl (e)-3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(C(C)C)C=C1C(C)C XRLCQRMNGQRGOC-MDZDMXLPSA-N 0.000 description 1
- XCRHYAQWBYDRGV-UHFFFAOYSA-N ethyl 3-(4-propan-2-ylphenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(C(C)C)C=C1 XCRHYAQWBYDRGV-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 229960005082 etohexadiol Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229940104869 fluorosilicate Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000003051 hair bleaching agent Substances 0.000 description 1
- 229910052864 hemimorphite Inorganic materials 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- GQXQIRNPJBUEGY-UHFFFAOYSA-N hexadecan-7-yl 2,2-dimethyloctanoate Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)C(C)(C)CCCCCC GQXQIRNPJBUEGY-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- QOSATHPSBFQAML-UHFFFAOYSA-N hydrogen peroxide;hydrate Chemical compound O.OO QOSATHPSBFQAML-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229940071145 lauroyl sarcosinate Drugs 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- YKWKFUUHPFWRNV-UHFFFAOYSA-N methyl 3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC=C(C(C)C)C=C1C(C)C YKWKFUUHPFWRNV-UHFFFAOYSA-N 0.000 description 1
- PABHEXWDYRTPBQ-UHFFFAOYSA-N methyl 3-[2,5-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC(C(C)C)=CC=C1C(C)C PABHEXWDYRTPBQ-UHFFFAOYSA-N 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- KELHQGOVULCJSG-UHFFFAOYSA-N n,n-dimethyl-1-(5-methylfuran-2-yl)ethane-1,2-diamine Chemical compound CN(C)C(CN)C1=CC=C(C)O1 KELHQGOVULCJSG-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000017524 noni Nutrition 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 229910000273 nontronite Inorganic materials 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 101150019841 penP gene Proteins 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- LYXOWKPVTCPORE-UHFFFAOYSA-N phenyl-(4-phenylphenyl)methanone Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 LYXOWKPVTCPORE-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000013308 plastic optical fiber Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 239000013309 porous organic framework Substances 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 229940096992 potassium oleate Drugs 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- MLICVSDCCDDWMD-KVVVOXFISA-M potassium;(z)-octadec-9-enoate Chemical compound [K+].CCCCCCCC\C=C/CCCCCCCC([O-])=O MLICVSDCCDDWMD-KVVVOXFISA-M 0.000 description 1
- PYJBVGYZXWPIKK-UHFFFAOYSA-M potassium;tetradecanoate Chemical compound [K+].CCCCCCCCCCCCCC([O-])=O PYJBVGYZXWPIKK-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- ALDITMKAAPLVJK-UHFFFAOYSA-N prop-1-ene;hydrate Chemical group O.CC=C ALDITMKAAPLVJK-UHFFFAOYSA-N 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- WZXKPNYMUZGZIA-RMKNXTFCSA-N propyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCOC(=O)\C=C\C1=CC=C(OC)C=C1 WZXKPNYMUZGZIA-RMKNXTFCSA-N 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940029039 propylene glycol alginate ester Drugs 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 238000013441 quality evaluation Methods 0.000 description 1
- 229940051201 quinoline yellow Drugs 0.000 description 1
- 239000004172 quinoline yellow Substances 0.000 description 1
- 235000012752 quinoline yellow Nutrition 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- 239000007687 r3 medium Substances 0.000 description 1
- 101150079601 recA gene Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 229910000275 saponite Inorganic materials 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 239000013606 secretion vector Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 231100000370 skin sensitisation Toxicity 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- IHQKEDIOMGYHEB-UHFFFAOYSA-M sodium dimethylarsinate Chemical compound [Na+].C[As](C)([O-])=O IHQKEDIOMGYHEB-UHFFFAOYSA-M 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-N sodium;2-[dodecanoyl(methyl)amino]acetic acid Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC(O)=O KSAVQLQVUXSOCR-UHFFFAOYSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- ZNYIJXQYUNSKDX-NTISSMGPSA-M sodium;hydron;(2s)-2-(tetradecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O ZNYIJXQYUNSKDX-NTISSMGPSA-M 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000019385 spermaceti wax Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229920003179 starch-based polymer Polymers 0.000 description 1
- 239000004628 starch-based polymer Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- JLGLQAWTXXGVEM-UHFFFAOYSA-N triethylene glycol monomethyl ether Chemical compound COCCOCCOCCO JLGLQAWTXXGVEM-UHFFFAOYSA-N 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 239000002383 tung oil Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- AZJYLVAUMGUUBL-UHFFFAOYSA-A u1qj22mc8e Chemical compound [F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O=[Si]=O.O=[Si]=O.O=[Si]=O.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 AZJYLVAUMGUUBL-UHFFFAOYSA-A 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000004520 water soluble gel Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
゛ 〔産業上の利用分野〕
本発明はエラスチンの前駆体蛋白質トロポエラスチンを
含有する皮膚外用剤に関し、特には遺伝子工学の技術に
よって得たトロポエラスチンを含有する皮膚外用剤に関
する。[Detailed Description of the Invention] [Field of Industrial Application] The present invention relates to a skin preparation for external use containing tropoelastin, a precursor protein of elastin, and particularly to a skin preparation containing tropoelastin obtained by genetic engineering technology. Regarding external preparations.
〔従来の技術および発明が解決し、1−1うとする問題
点〕
エラスチン(成熟エラスチン)シ、1、コラーゲンや酸
性ムコ多IIM irどと同様に動物の結合&I]Hの
一成分であり、肺、大動脈、靭帯、皮膚などの弾力性を
有する臓器に存在している。、二わらのエラスチンは、
複雑な架橋構造をもつ分7−1数十万1ソ1−の高分子
蛋白質であるため、水に不溶14であり、抽出、純化が
むすかしい。一般に、エラスチンの抽出・分離は、組織
を強アルカリで処理したり、高温で処理するなど苛酷な
条件で抽出を行ない、エラスチンを分解物として分離す
る方法が行なわれている。エラスチンを比較的高分子で
得る方法としては、Partridge らの熱シュウ
酸処理法(Partridge等、旧ochem、J、
61 、11.1955)か知られており、水溶性蛋白
質としてα−エラスチン[分子量約70KDa (キ
ロダルトン)]と]β−エラスチン分子量約10KDa
J≧2下]とが得られている。最近ではα−エラスチン
を用いたエラスチンの生理作用の研究も進められており
、動脈硬化の要因となる皿小板の凝集を阻害する機能を
α−エラスチンが持つことが明らかになってきている。[Problems to be solved by the prior art and the invention 1-1] Elastin (mature elastin), 1. Like collagen and acid mucopolymerase, it is a component of animal binding &I]H, It is present in elastic organs such as the lungs, aorta, ligaments, and skin. , two straw elastin is
Because it is a high-molecular protein with a complex crosslinked structure and several hundreds of thousands of molecules, it is insoluble in water and difficult to extract and purify. Generally, elastin is extracted and separated by a method in which tissue is extracted under harsh conditions such as treatment with a strong alkali or high temperature, and elastin is separated as a decomposed product. As a method for obtaining elastin with a relatively high molecular weight, there is a hot oxalic acid treatment method by Partridge et al. (formerly Ochem, J.
61, 11.1955), and α-elastin [molecular weight approximately 70 KDa (kilodaltons)] and β-elastin [molecular weight approximately 10 KDa] are known as water-soluble proteins.
J≧2 lower] is obtained. Recently, research on the physiological effects of elastin using α-elastin has been progressing, and it has become clear that α-elastin has the ability to inhibit platelet aggregation, which is a factor in arteriosclerosis.
トロポエラスチンは、エラスチン蛋白質の前駆体であり
、伝令RNAから翻訳された直後の水溶性蛋白質である
。成W1エラスチンと異なり、デスモシン、イソデスモ
シン、リジノノルロイシンを残基として含有せず、また
それらによる架橋も形成していない。生体からのトロポ
エラスチンの分離は、非常にむずかしく、架橋形成酵素
を阻害するために銅欠乏食餌を与えた幼若動物のMi織
から分離する方法(Smith;D、W、等、旧och
em、Riophys。Tropoelastin is a precursor of elastin protein, and is a water-soluble protein immediately translated from messenger RNA. Unlike adult W1 elastin, it does not contain desmosine, isodesmosine, or lysinonorleucine as residues, nor does it form crosslinks with them. Isolation of tropoelastin from living organisms is very difficult, and a method for isolating it from the Mi tissue of young animals fed a copper-deficient diet to inhibit cross-linking enzymes (Smith; D, W, et al., formerly och.
em, Riophys.
Res、Commum、31,309.1968)が知
られているが、単離できるI−ロボエラスチンは非常に
微量である。Res, Commun, 31, 309.1968), but the amount of I-roboelastin that can be isolated is very small.
このため、トロポエラスチンの分子構造等の研究はなか
なか進まず、分子量、アミノ酸組成が明らかになった程
度である。従って、トロポエラスチンの産業界への応用
はこれまで全く検討されていなかった。For this reason, research into the molecular structure of tropoelastin has not made much progress, and only the molecular weight and amino acid composition have been clarified. Therefore, the application of tropoelastin to industry has not been considered at all so far.
本発明者らは、トロポエラスチンの構造をDNAレヘル
で解明し、組換え1)NA技術を用いて、トロポエラス
チンを微生物により大量生産することに成功した。The present inventors elucidated the structure of tropoelastin using DNA chemistry and succeeded in mass-producing tropoelastin using a microorganism using recombinant 1) NA technology.
そこで、本発明者らは、大量に得られたトロポエラスチ
ンの特性を検討したところ、トロポエラスチンには優れ
た肌荒れ防1ト効果および肌荒れ改善効果があることを
見出した。Therefore, the present inventors investigated the characteristics of tropoelastin obtained in large quantities and found that tropoelastin has an excellent effect on preventing and improving skin roughness.
従って、本発明の目的は優れた肌荒れ防止効果および肌
荒れ改善効果をもつ皮膚外用剤を提供することにある。Therefore, an object of the present invention is to provide a skin preparation for external use that has excellent effects on preventing and improving skin roughness.
前記の目的は、トロポエラスチンを含有する皮膚外用剤
、特には遺伝子工学の技術によって得たトロポエラスチ
ンを含有する皮膚外用剤によって達成することができる
。The above object can be achieved by an external skin preparation containing tropoelastin, particularly a skin external preparation containing tropoelastin obtained by genetic engineering techniques.
以下、本発明を更に詳細に説明する。The present invention will be explained in more detail below.
まず、トロポエラスチンをコードする伝令RNAに対す
るcDNAの作製方法についてjホベる。First, we will discuss the method for producing cDNA for the messenger RNA encoding tropoelastin.
ヒト、うシ、ブタ、ヒツジ、ニワトリまたはマウスにお
いて、エラスチンを多く生産する組織(lソ下、プラス
組織ということがある)例えば前記各動物の大動脈をグ
アニジルチオシアネートとともにホモジナイズすること
により細胞を破砕し、塩化セシウム平衡密度勾配超遠心
分離によりRNA分画を得る。続いてオリゴdTセルロ
ースを担持したアフィニティークロマトグラフィーによ
り、前記RNA分画からポリAを持つRNA (ポリA
3RNA)を単離する。In humans, cows, pigs, sheep, chickens, or mice, tissues that produce a large amount of elastin (sometimes referred to as plus tissues), for example, the aorta of each of the above animals, are homogenized with guanidyl thiocyanate to obtain cells. The RNA fraction is obtained by disruption and cesium chloride equilibrium density gradient ultracentrifugation. Subsequently, by affinity chromatography supporting oligo dT cellulose, polyA-bearing RNA (polyA
3 RNA) is isolated.
このポリA″I?NAを鋳型として使用し、公知の方法
、好ましくは岡山−Be、rgの方法(Mo1.Ce1
l。Using this polyA''I?NA as a template, a known method, preferably the method of Okayama-Be, rg (Mo1.Cel.
l.
Biol、2.16+、1982)によって、cDNA
ライブラリーを得る。岡山−Bergの方法は以下のよ
うに実施する。すなわち、岡山−Rergのベクターの
ポリT部分にポリA” RNAのポリA部分を吸着させ
、逆転写酵素を反応させて、cDNAを合成する。Biol, 2.16+, 1982), cDNA
Get the library. The Okayama-Berg method is carried out as follows. That is, the polyA part of polyA'' RNA is adsorbed to the polyT part of the Okayama-Rerg vector, and cDNA is synthesized by reacting with reverse transcriptase.
ターミナルデオキシヌクレオチジルトランスフエラーゼ
でオリゴdCをcDNAの3′未満に付加した後、制限
酵素ll1ndIIIでベクターDNAを切断する。オ
リゴdGリンカ−を連結してからベクターを環状化した
後、RNA部分をr)NAボリメラ一ゼでDNAに置換
し、cDNA含有プラスミドを得る。これらのプラスミ
ドを用いて、塩化カルシうム法(Strjk、 Po等
、J、Bacteriol、I38.1033゜197
9)などの方法により大腸菌を形質転換する。After adding oligo dC to the 3' end of the cDNA using terminal deoxynucleotidyl transferase, the vector DNA is cut with restriction enzyme ll1ndIII. After ligating an oligo-dG linker and circularizing the vector, the RNA portion is replaced with DNA using r) NA polymerase to obtain a cDNA-containing plasmid. Using these plasmids, the calcium chloride method (Strjk, Po et al., J. Bacteriol, I38.1033°197
Transform E. coli using a method such as 9).
アンピシリン添加平板培地にてアンピシリンit 性株
を選択することにより、プラスミド受容菌を取得する。Plasmid-receiving bacteria are obtained by selecting ampicillin-specific strains on a plate medium supplemented with ampicillin.
一方、前記のプラス組織すなわちエラスチンを多く生産
する組織と、エラスチンをあまり生産しない組織(以下
、マイナス組織ということがある)例えば前記各動物の
皮膚を用意し、それぞれの細胞から上述の方法などによ
ってポリA″RNAを単離する。ポリヌクレオチドキナ
ーゼとγ−ff2pATPとを用いてRNAの5’OH
を32pでラヘルし、これをプローブとする。On the other hand, the above-mentioned plus tissue, that is, the tissue that produces a lot of elastin, and the tissue that does not produce much elastin (hereinafter sometimes referred to as minus tissue), for example, the skin of each of the animals mentioned above, are prepared, and the cells of each are extracted by the method described above. Isolate polyA″ RNA. Polynucleotide kinase and γ-ff2pATP are used to convert the 5′OH
Rahel with 32p and use this as a probe.
次に、コロニーハイブリダイゼーション法(Hanah
an、 D、等、 Gene、 10.63.1980
)により、上述のcDNAライブラリーの中からプラス
組織由来のプローブと相補性があり、しかもマイナス組
織由来のプローブと相補性がないコロニーを選択する。Next, colony hybridization method (Hanah
an, D, et al., Gene, 10.63.1980
), a colony is selected from the cDNA library described above that has complementarity with the probe derived from the plus tissue and has no complementarity with the probe derived from the minus tissue.
こうして選択したコロニーからプラスミドDNAを取得
し、ジデオキシヌクレオチド法(Messing、J、
Methods in Enzymology 101
+20+1983)などにより、塩基配列を決定する。Plasmid DNA was obtained from the colonies selected in this way, and the dideoxynucleotide method (Messing, J.
Methods in Enzymology 101
+20+1983) etc. to determine the base sequence.
塩基配列からアミノ酸配列を推定し、そのアミノ酸配列
の中にエラスチン特有のアミノ酸配列が存在することを
次に、前記のcDNAを適当な発現ベクターにN、■込
む。The amino acid sequence is deduced from the base sequence, and it is determined that an amino acid sequence unique to elastin is present in the amino acid sequence.Next, the above cDNA is inserted into an appropriate expression vector.
発現ベクターとしては、大腸菌糸、枯草菌系および酵母
系で開発されている発現ベクター系を使用することがで
きる。As the expression vector, expression vector systems developed for E. coli hyphae, Bacillus subtilis system, and yeast system can be used.
大腸菌糸の発現ベクター系としては、pOMPoまたは
pOP95−13(0,Mercerau−Puija
lon等、Nature。Expression vector systems for E. coli hyphae include pOMPo or pOP95-13 (0, Mercerau-Puija
lon et al., Nature.
275.505.1978)などの発現ベクターで代表
されるIacプロモーター系、pKK223−3(H,
A、de Boer等、Proc、Natl、八cad
、sci、[IsA、80.21.1983)またはp
DR540(口、R,Ru5se1等、Gene、20
,231.1982)などの発現ベクターで代表される
tacプロモーター系、ptrpLl(J、C,Edn
+an等、Na ture+ 291 + 503+
1981)またはpBN37(T、H,Frazer等
、Proc、Natl、Acad、Sci、ll5A。275.505.1978), pKK223-3 (H,
A, de Boer et al., Proc, Natl, 8 cad.
, sci, [IsA, 80.21.1983) or p
DR540 (mouth, R, Ru5se1, etc., Gene, 20
, 231. 1982), ptrpLl (J, C, Edn.
+an etc., Nature+ 291 + 503+
1981) or pBN37 (T, H, Fraser et al., Proc, Natl, Acad, Sci, ll5A.
75.5936.1978)などの発現ベクターで代表
されるtrpプロモーター系、pKT279(K、Ta
lmadge等、Proc’、Natl、Acad、S
ci、ll5A、77.3988.1980)またはp
KT287(K、Talmadge等、Proc、Na
tl、Acad 、 Sc i 、 USA。75.5936.1978), pKT279 (K, Ta
lmadge etc., Proc', Natl, Acad, S
ci, ll5A, 77.3988.1980) or p
KT287 (K, Talmadge et al., Proc, Na
tl, Acad, Sci, USA.
77、3369.1980)などの発現ベクターで代表
されるblaプロモーター系、pMH621(T、Ma
niatis、Mo1e−cular Cloning
、 Co1d Spring Harbor Lab、
1982)で代表されるompプロモーター系、pIN
−1またはprM−T(Y、Masui等、Exper
imental ManipulationofGen
e Eにpression+ M、InouyefJi
)、p15.^cademicPress、 1983
)などの発現ベクターで代表されるLppプロモーター
系、pMCR−545(T、Miki等、Mol。77, 3369.1980), pMH621 (T, Ma
niatis, Mo1e-cular Cloning
, Co1d Spring Harbor Lab,
omp promoter system represented by (1982), pIN
-1 or prM-T (Y, Masui et al., Expert
mental Manipulation of Gen
e Pression + M on E, InouyefJi
), p15. ^ academic Press, 1983
), pMCR-545 (T, Miki et al., Mol.
Gen、Genet、183,25.1981)で代表
されるrecAプロモーター系等を使用することができ
る。The recA promoter system typified by Gen. Genet, 183, 25. 1981) can be used.
枯草菌の発現ベクターとしては、ペニシリナーゼのプロ
モータを用いたpenP(D、Henner等、2nd
Tnt、Conference of Genetic
s and Biotechnologyof Bac
illi、1983)、 α−アミラーセ遺伝子のプ
ロモーターとシグナルペプチド遺伝子領域を用いたpK
TI+93 (1、Pa I va等、Gene、22
,229.1983)また番オペニシリナーゼのプロモ
ーターとシグナルペプチド遺伝子を用いた発現ベクター
(S、Chang等、門01e−cular Clon
ing and Gene Regulation i
n Bacilli。As an expression vector for Bacillus subtilis, penP (D, Henner et al., 2nd
Tnt, Conference of Genetic
s and Biotechnology of Bac
illi, 1983), pK using the α-amylase gene promoter and signal peptide gene region.
TI+93 (1, Pa I va etc., Gene, 22
, 229. 1983) Expression vector using the promoter and signal peptide gene of openicillinase (Chang et al., S., Phylum 01e-cular Clone
ing and Gene Regulation i
n Bacilli.
p159.Academic Press、1982)
などを使用することができる。p159. Academic Press, 1982)
etc. can be used.
酵母の発現ベクターとしては、グルタルアルデヒド3リ
ン酸デヒドロゲナーゼのプロモーターを用いたpGl’
DIまたはpGPI12(G、八、Bitter等、G
ene+32、263.1984)など、α1フアクタ
ーのプロモーターとシグナルペプチド遺伝子を持つpM
Fα8(A。As a yeast expression vector, pGl' using the glutaraldehyde 3-phosphate dehydrogenase promoter is used.
DI or pGPI12 (G, 8, Bitter et al., G
pM with α1 factor promoter and signal peptide gene, such as ene+32, 263.1984)
Fα8(A.
Miyaj ima等、Gene、37,155.19
85) 、アルコールデヒドロゲナーゼのプロモーター
を用いたAA)15または八H5(G、Ammerer
、Methods in [Enzymology
(R,Wue等W)Vollol、p192+Acad
emic Press、1983) 、GALIOプロ
モーターを用いたYEp51またはYRp52(J、R
。Miyaj ima et al., Gene, 37,155.19
85), AA) 15 or 8H5 (G, Ammerer) using the promoter of alcohol dehydrogenase.
, Methods in [Enzymology
(R, Wue etc. W) Vollol, p192+Acad
emic Press, 1983), YEp51 or YRp52 (J,R
.
Broach等、lixperimental Man
ipulation of GeneExpressi
on(M、Inouye m)p83.Academi
c Press。Broach etc., lixperimental Man
ipulation of GeneExpressi
on (M, Inouye m) p83. Academy
cPress.
1983) 、GAI、7プロモーターを用いた発現ベ
クター(特開昭60−248181号)、抑制型酸性フ
ォスファターゼプロモーターを用いたpAT77またC
才pAl’1F12(^、旧yanohara 等、
Proc、Natl、八cad、sci、ll5A、
80+L1983)などを使用することができる。トロ
ポエラスチンのcDNAは、エンドヌクレアーゼBa1
31部分消化などにより、適当なりローニング部位を作
製し、各種発現ベクター基のクローニング部位に挿入し
、トロポエラスチンcDNA発現ベクターを作製する。1983), expression vector using GAI, 7 promoter (Japanese Patent Application Laid-open No. 60-248181), pAT77 or C using repressible acid phosphatase promoter.
SaipAl'1F12 (^, former yanohara etc.,
Proc, Natl, 8cad, sci, ll5A,
80+L1983) etc. can be used. Tropoelastin cDNA is endonuclease Ba1
A suitable cloning site is created by partial digestion or the like, and inserted into the cloning site of various expression vector groups to create a tropoelastin cDNA expression vector.
トロポエラスチン発現ベクターの作製は、発現ベクター
系のプロモーターまたは、シグナルペプチド下流のクロ
ーニング部位にcDNAの5′末端を連結する。このと
き、シグナルペプチド部分をもつものでは、読みわく
(コーディングフレーム)を合わせる必要があり、また
翻訳開始コト°ン(ATGなど)がない発現ベクター系
では、cDNAのATGがクローニング部位下流近傍に
なるように留意する。To construct a tropoelastin expression vector, the 5' end of the cDNA is ligated to the promoter of the expression vector system or to the cloning site downstream of the signal peptide. At this time, for those with a signal peptide moiety,
(coding frames), and in expression vector systems that do not have a translation initiation coton (ATG, etc.), care should be taken to ensure that the ATG of the cDNA is located near the downstream of the cloning site.
このようにして得られたトロポエラスチン発現ベクター
を、宿主(大腸菌、枯草菌または酵母)に導入する。形
質転換はjm常の方法を用いることができる。The tropoelastin expression vector thus obtained is introduced into a host (E. coli, Bacillus subtilis, or yeast). For transformation, conventional methods can be used.
大腸菌の形質転換は、カルシウム処理法(Mandel
等、J、Mo1.Bio+、53.159.1970)
に従って行うことができる。枯草菌の形質転換は、プロ
トプラスト法(S、Chang等、Mo+、Gen、G
enet、168,111.1979)に従って行う。Transformation of E. coli was performed using the calcium treatment method (Mandel
et al., J. Mo1. Bio+, 53.159.1970)
This can be done according to the following. Transformation of Bacillus subtilis was performed using the protoplast method (S, Chang et al., Mo+, Gen, G
enet, 168, 111.1979).
また、酵母の形質転換は、スフェロプラスト法(A、t
linnen等、Proc、Natl、八cad、Sc
i。In addition, yeast transformation can be performed using the spheroplast method (A, t
Linnen et al., Proc, Natl, 8cad, Sc
i.
11sA、 75.1929.1978)及び塩化リチ
う方法(11,Ito等、J、Bacteriol、1
53,163.1983)に従って行う。11sA, 75.1929.1978) and the lithium chloride method (11, Ito et al., J. Bacteriol, 1
53, 163.1983).
形質転換体は、それぞれの発現ベクターに組込まれた選
択マーカー(例えばアンピシリン耐性)により平板培地
」−で選択することにより得られる。Transformants are obtained by selection on a plate using a selection marker (eg, ampicillin resistance) incorporated into the respective expression vector.
得られた形質転換体の培養は以下のように実施する。The obtained transformant is cultured as follows.
大腸菌または枯草菌については、TYG培地(トリプト
ン0.5%、酵母エキス0.5%、ブドウ110.1%
、KzHPO4,0,1%)またはL B培地(トリプ
トン1%、酵母エキス0.5%、食塩1%)などの一般
に大腸菌または枯草菌が生育する培地に、トロポエラス
チン発現ベクターの選択マーカーである抗生物質(アン
ピシリン、カナマイシン等)を適当量加えた培地を使用
して培養する。短時間の培養であれば、抗生物質は必ず
しも必要でない。For E. coli or Bacillus subtilis, use TYG medium (tryptone 0.5%, yeast extract 0.5%, grape 110.1%
, KzHPO4,0,1%) or LB medium (tryptone 1%, yeast extract 0.5%, salt 1%), a medium in which E. coli or Bacillus subtilis is generally grown, with a selection marker for the tropoelastin expression vector. Culture is performed using a medium containing an appropriate amount of a certain antibiotic (ampicillin, kanamycin, etc.). Antibiotics are not necessarily required for short-term culture.
培養は、25〜45℃の範囲で振とうして行う。平板培
地」二の形質転換株を5〜100mβの上記培地で1夜
振とう培養し、50〜10100O00の培地に移し、
10〜30時間培養を行う。Culture is performed at a temperature of 25 to 45°C with shaking. The transformed strain of "plate medium" 2 was cultured with shaking in the above medium of 5 to 100 mβ overnight, transferred to a medium of 50 to 10100000,
Culture is carried out for 10 to 30 hours.
酵母については、最小培地[0,7%酵母窒素源ヘース
(アミノ酸を含まない)、2%グ月/:1−ス、20
m g 71程度の各種核酸およびアミノ酸]を用い、
各種発現ベクターの持つ選択マーカー(例えば、ウラシ
ル、■、−ロイシンなど)を除いた培地を作製して使用
する。培養は、25〜35℃の範囲で振とうして行う。For yeast, minimal medium [0.7% yeast nitrogen source hese (no amino acids), 2% g/:1-s, 20
Using various nucleic acids and amino acids of about 71 mg,
A medium is prepared and used that excludes selection markers (for example, uracil, ■, -leucine, etc.) possessed by various expression vectors. Culture is performed at a temperature of 25 to 35°C with shaking.
平板培地」二の形質転換株は5〜100 mnの培地で
1〜2日振とう培養し、50〜1000000m lの
培地に移し、1〜5日間培養を行う。The transformed strain in plate medium 2 is cultured with shaking in a 5-100 ml medium for 1-2 days, transferred to a 50-1,000,000 ml medium, and cultured for 1-5 days.
培養により得られたトロポエラスチンの採取は次のよう
に行う。Tropoelastin obtained by culture is collected as follows.
分泌ベクター系で生産したトロポエラスチンは、培養液
を遠心分離し、上清を得る。また、それ以外のベクター
系では、菌体を得、さらに菌体を水で洗浄後、超音波処
理、フレンチプレス、Xプレス、ヒユープレス、ダウン
ス管等の細胞破壊装置を用いて菌体を破壊し、遠心分離
により上清液を得る。For tropoelastin produced using a secretion vector system, the culture solution is centrifuged to obtain a supernatant. In addition, for other vector systems, the bacterial cells are obtained, and after washing the bacterial cells with water, the bacterial cells are destroyed using a cell destruction device such as ultrasonication, French press, X press, Hue press, Dounce tube, etc. , obtain the supernatant by centrifugation.
これらの上清をアセトン沈殿、限外濾過、凍結乾燥等に
より濃縮し、オープンカラムを用いたゲル濾過イオン交
換クロマトグラフィー等により部分精製し、さらに、I
IPLc 、 FPLC等を用いた高速流体クロマトグ
ラフィーによって精製する。These supernatants were concentrated by acetone precipitation, ultrafiltration, freeze-drying, etc., partially purified by gel filtration ion exchange chromatography using an open column, and then I
Purify by high performance fluid chromatography using IPLc, FPLC, etc.
こうして得られるトロポエラスチンは、伝令RNAを抽
出する生物種および抽出細胞によってアミノ酸配列が少
しづつ異なる。しかし、いずれのトロポエラスチンもア
ミノ酸配列の上で次の3つの条件を満している。The amino acid sequence of the tropoelastin thus obtained differs slightly depending on the species of organism from which the messenger RNA is extracted and the cells from which it is extracted. However, all tropoelastins satisfy the following three conditions in terms of their amino acid sequences.
(1)■、−バリン−L−プロリン−グリシン−■、−
バリン−グリシンで示されるペンタペプチド領域を全ア
ミノ酸配列中に複数個持つ。(1)■,-valine-L-proline-glycine-■,-
It has multiple pentapeptide regions represented by valine-glycine in its entire amino acid sequence.
(2)L−プロリン−14−アラニン−■、−アラニン
−I7−アラニン−I、−アラニン−■、−リジンーL
−アラニンーL−アラニンで示されるオクタペプチド領
域をアミノ酸配列中に持つ。(2) L-proline-14-alanine-■, -alanine-I7-alanine-I, -alanine-■, -lysine-L
-Alanine - Contains an octapeptide region represented by L-alanine in its amino acid sequence.
(3)ヒドロキシプロリン、デスモシン、イソデスモシ
ン、リジノノルロイシン等の転写後の修飾により形成さ
れる残基をアミノ酸配列中に持たない。(3) The amino acid sequence does not contain residues formed by post-transcriptional modifications such as hydroxyproline, desmosine, isodesmosine, and lysinonorleucine.
本発明の皮膚外用剤は、前記のトロポエラスチンを0.
0001〜10重量%好ましくは0.旧〜5重量%の量
で含む。The skin external preparation of the present invention contains the above-mentioned tropoelastin at 0.
0001-10% by weight, preferably 0.0001-10% by weight. Contains in an amount of ~5% by weight.
本発明の皮膚外用剤とは、ヒトの皮膚に塗布して化粧品
、医薬部外品または医薬品に利用できるものをいう。The external skin preparation of the present invention refers to one that can be applied to human skin and used as cosmetics, quasi-drugs, or pharmaceuticals.
本発明の皮膚外用剤は上記の必須成分に加えて必要に応
じて、化粧品、医薬品等に一般に用いられる各種成分、
すなわち水性成分、粉末成分、油分、界面活性剤、保湿
剤、増粘剤、防腐剤、紫外線吸収剤、色剤、酸化防止剤
、香料、薬剤等を配合することができる。In addition to the above-mentioned essential ingredients, the external skin preparation of the present invention may optionally include various ingredients commonly used in cosmetics, pharmaceuticals, etc.
That is, an aqueous component, a powder component, an oil component, a surfactant, a humectant, a thickener, a preservative, an ultraviolet absorber, a coloring agent, an antioxidant, a fragrance, a drug, etc. can be blended.
以下に代表的な配合成分およびその代表例を説明するが
、本発明の外用剤に配合できる成分は以下のものに限定
されるわけではない。Typical ingredients and their typical examples will be explained below, but the ingredients that can be included in the external preparation of the present invention are not limited to the following.
パール光沢付与剤としては、例えば天然魚M箔、雲母−
酸化チタン系複合材、オキシ塩化ビスマス等が挙げられ
る。また、これらを親水化または親油化処理した処理粉
末もパール光沢付与剤として用いられる。Examples of pearl luster imparting agents include natural fish M foil, mica-
Examples include titanium oxide composites and bismuth oxychloride. In addition, treated powders obtained by making these powders hydrophilic or lipophilic can also be used as pearl luster imparting agents.
合成エステルとしては、例えばミリスチン酸イソプロピ
ル、オクタン酸セチル、ミリスチン酸オクチルドデシル
、パルミチン酸イソプロピル、ステアリン酸ブチル、ラ
ウリン酸ヘキシル、ミリスチン酸ミリスチル、オレイン
酸デシル、ジメチルオクタン酸へキシルデシル、乳酸セ
チル、乳酸ミリスチル、酢酸ラノリン、ステアリン酸イ
ソセチル、イソステアリン酸イソセチル、12−ヒドロ
キシステアリル酸コレステリル、ジー2−エチルヘキシ
ル酸エチレングリコール、ジペンタエリスリトール脂肪
酸エステル、モノイソステアリン酸N−アルキルグリコ
ール、シカプリン酸ネオペンチルグリコール、リンゴ酸
ジイソステアリル、ジー2−ヘプチルウンデカン酸グリ
セリン、トリー2−エチルヘキシル酸トリメチロールプ
ロパン、トリイソステアリン酸トリメチロールプロパン
、テトラ−2−エチルヘキシル酸ペンタンエリスリトー
ル、トリー2−エチルへキシル酸グリセリン、トリイソ
ステアリン酸トリメチロールプロパン、セチル2−エチ
ルヘキサノエート、2−エチルへキシルパルミテート、
トリミリスチン酸グリセリン、トリー2−ヘプチルうン
デカン酸グリセライド、ヒマシ油脂肪酸メチルエステル
、オレイン酸オイル、セトステアリルアルコール、アセ
トグリセライド、パルミチン酸2−ヘプチルウンデシル
、アジピン酸ジイソブチル、N−ラウロイル−L−グル
タミン酸−2−オクチルドデシルエステル、アジピン酸
ジー2−ヘプチルウンデシル、エチルラウレート、セパ
チン酸ジー2−エチルヘキシル、ミリスチン酸2−へキ
シルデシル、パルミチン酸2−へキシルデシル、アジピ
ン酸2−へキシルデシル、セパチン酸ジイソプロピル、
コハク酸2−エチルヘキシル、酢酸エチル、酢酸ブチル
、酢酸アミル、クエン酸トリエチル等が挙げられる。Examples of synthetic esters include isopropyl myristate, cetyl octoate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyldecyl dimethyloctanoate, cetyl lactate, myristyl lactate. , lanolin acetate, isocetyl stearate, isocetyl isostearate, cholesteryl 12-hydroxystearate, ethylene glycol di-2-ethylhexylate, dipentaerythritol fatty acid ester, N-alkyl glycol monoisostearate, neopentyl glycol capriate, dimalate Isostearyl, glyceryl di-2-heptylundecanoate, trimethylolpropane tri-2-ethylhexylate, trimethylolpropane triisostearate, pentaneerythritol tetra-2-ethylhexylate, glyceryl tri-2-ethylhexylate, trimethylol triisostearate Propane, cetyl 2-ethylhexanoate, 2-ethylhexyl palmitate,
Glycerin trimyristate, tri-2-heptylundecanoic acid glyceride, castor oil fatty acid methyl ester, oleic acid oil, cetostearyl alcohol, acetoglyceride, 2-heptylundecyl palmitate, diisobutyl adipate, N-lauroyl-L-glutamic acid -2-octyldodecyl ester, di-2-heptylundecyl adipate, ethyl laurate, di-2-ethylhexyl cepatate, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, 2-hexyldecyl adipate, cepatic acid diisopropyl,
Examples include 2-ethylhexyl succinate, ethyl acetate, butyl acetate, amyl acetate, triethyl citrate, and the like.
合成樹脂エマルジョンとしては、例えばアクリル樹脂エ
マルジョン、ポリアクリル酸エチルエマルジョン、了ク
リルレジン液、ポリアクリルアルキルエステルエマルジ
ョン
エマルジョン等が挙げられる。Examples of the synthetic resin emulsion include acrylic resin emulsion, polyethyl acrylate emulsion, acrylic resin liquid, polyacrylic alkyl ester emulsion, and the like.
有機アミンとしては、例えばモノエタノールアミン、ジ
ェタノールアミン、トリエタノールアミン、モルホリン
、トリイソプロパツールアミン、2〜アミノ−2−メチ
ル−1,3−プロパンジオール、2−アミノ−2−メチ
ル−1−プロパツール等が挙げられる。Examples of organic amines include monoethanolamine, jetanolamine, triethanolamine, morpholine, triisopropanolamine, 2-amino-2-methyl-1,3-propanediol, 2-amino-2-methyl-1 - Examples include property tools.
無機粉末としては、例えばタルク、酸化チタン、カオリ
ン、無水ケイ酸、ケイ酸塩、酸化亜鉛、炭酸カルシうム
、炭酸マグネシウム、ベンガラ、黄酸化鉄、酸化クロム
、カーボンブランク、群青、雲母、セリサイト、ナイロ
ンパウダー、ポリエチレン末、セルロースパウダー、ア
クリル系樹脂、二酸化チタン、酸化鉄等が挙げられる。Examples of inorganic powders include talc, titanium oxide, kaolin, anhydrous silicic acid, silicate, zinc oxide, calcium carbonate, magnesium carbonate, red iron oxide, yellow iron oxide, chromium oxide, carbon blank, ultramarine blue, mica, and sericite. , nylon powder, polyethylene powder, cellulose powder, acrylic resin, titanium dioxide, iron oxide, etc.
無機顔料としては、例えばタルク、カオリン、炭酸カル
シウム、亜鉛華、二酸化チタン、赤酸化鉄、黄酸化鉄、
黒酸化鉄、群青、チタンコーティソドマイ力、オキシ塩
化ビスマス、ヘンガラ、粘結顔料、グンジョウピンク、
水酸化クロム、雲母チタン、黄酸化鉄、酸化クロム、酸
化アルミニうムコバルト、紺青、黒酸化鉄、カーボンブ
ランク、無水ケイ酸、ケイ酸マグネシウム、ベントナイ
ト、マイカ、酸化ジルコニウム、酸化マグネジうム、酸
化亜鉛、酸化チタン、軽質炭酸カルシうム、重質炭酸カ
ルシウム、軽質炭酸マグネシウム、重質炭酸マグネジう
ム、カラミン等が挙げられる。Examples of inorganic pigments include talc, kaolin, calcium carbonate, zinc white, titanium dioxide, red iron oxide, yellow iron oxide,
Black iron oxide, ultramarine, titanium coati sodomite, bismuth oxychloride, hengara, caking pigment, gunjo pink,
Chromium hydroxide, titanium mica, yellow iron oxide, chromium oxide, aluminum oxide, mucobalt oxide, dark blue, black iron oxide, carbon blank, silicic anhydride, magnesium silicate, bentonite, mica, zirconium oxide, magnesium oxide, zinc oxide , titanium oxide, light calcium carbonate, heavy calcium carbonate, light magnesium carbonate, heavy magnesium carbonate, calamine, and the like.
親油性非イオン界面活性剤としては、例えば、ソルビタ
ンモノオレエート、ソルビクンモノイソステアレート、
ソルビクンモノラウレート、ソルビタンモノパルミテー
ト、ソルビタンモノステアレート、ソルビタンセスキオ
レエート、ソルビタントリオレエート、ペンタ−2−エ
チルへキシル酸ジグリセロールソルビクン、テトラ−2
−エチルヘキシル酸ジグリセロールソルビタン等のソル
ビタン脂肪酸エステル類、モノ綿実油脂肪酸グリセリン
、モノエルカ酸グリセリン、セスキオレイン酸グリセリ
ン、モノステアリン酸グリセリン、α、α′−オレイン
酸ピログルタミン酸グリセリン、モノステアリン酸グリ
セリンリンゴ酸等のグリセリンポリグリセリン脂肪酸類
、モノステアリン酸プロピレングリコール等のプロピレ
ングリコール脂肪酸エステル類、硬化ヒマシ油誘導体、
グリセリンアルキルエーテル等が挙げられる。Examples of lipophilic nonionic surfactants include sorbitan monooleate, sorbicun monoisostearate,
Sorbicum monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan sesquioleate, sorbitan trioleate, diglycerol pent-2-ethylhexylate, sorbicun, tetra-2
- Sorbitan fatty acid esters such as diglycerol sorbitan ethylhexylate, glyceryl monocottonseed oil fatty acid, glyceryl monoerucate, glyceryl sesquioleate, glyceryl monostearate, glyceryl pyroglutamate α, α′-oleate, glyceryl monostearate malic acid, etc. glycerin polyglycerin fatty acids, propylene glycol fatty acid esters such as propylene glycol monostearate, hydrogenated castor oil derivatives,
Examples include glycerin alkyl ether.
親水性非イオン界面活性剤としては、例えば、POEソ
ルビタンモノオレエート、POE−ソルビタンモノステ
アレート、POE−ソルビタンモノオレート、POEソ
ルビタンテトラオレエート等のPOEソルビタン脂肪酸
エステル類、POEソルビットモノラウレート、POF
、ソルビットモノオレエート、POEソルビットペンタ
オレエート、POEツルピントモノステアレート等のP
OEソルビット脂肪酸エステル類、POEグリセリンモ
ノステアレート、POEグリセリンモノイソステアレー
ト、POF、グリセリントリイソステアレート等のPO
Eグリセリン脂肪酸エステル類、POEモノオレエート
、POEジステアレート、P(’)Bモノオレエート、
ジステアリン酸エチレングリコール等のPOE脂肪酸エ
ステル類、P。Examples of the hydrophilic nonionic surfactant include POE sorbitan fatty acid esters such as POE sorbitan monooleate, POE-sorbitan monostearate, POE-sorbitan monooleate, and POE sorbitan tetraoleate, POE sorbitan monolaurate, P.O.F.
, sorbitol monooleate, POE sorbitolpentaoleate, POE turpinto monostearate, etc.
PO such as OE sorbitol fatty acid esters, POE glycerin monostearate, POE glycerin monoisostearate, POF, glycerin triisostearate, etc.
E glycerin fatty acid esters, POE monooleate, POE distearate, P(')B monooleate,
POE fatty acid esters such as ethylene glycol distearate, P.
Eラウリルエーテル、POEオレイルエーテル、POE
ステアリルエーテル、POEベヘニルエーテル、POE
2−オクチルドデシルエーテル、POEコレスタノール
エーテル等のPOEアルキルエーテル類、POEオクチ
ルフェニルエーテル、POEノニルフェニルエーテル、
POEジノニルフェニルエーテル等のPOEアルキルフ
ェニルエーテル類、プルロニック等のプルロニック型類
、POE −POPセチルエーテル、POI!・POP
2−デシルテトラデシルエーテル、POE −POP
モノブチルエーテル、POE −POP水添ラノリン、
POIE・POPグリセリンエーテル等のPOE −P
OPアルキルエーテル類、テトロニック等のテトラPO
E・テトラPOPエチレンジアミン縮合物類、POEヒ
マシ油、POE硬化ヒマシ油、POE硬化ヒマシ油モノ
イソステアレート、POE硬化ヒマシ油トワイソステア
レート、POE硬化硬化ヒマシフモノピログルタミン酸
モノイソステアリン酸ジエステルOE硬化硬化ヒマシシ
マレイン酸POEヒマシ油硬油上化ヒマシ油誘導体OE
ソルビットミツロウ等のPOEミツロウ・ラノリン誘導
体、ヤシ油脂肪酸ジェタノールアミド、ラウリン酸モノ
エタノールアミド、脂肪酸イソプロパツールアミド等の
アルカノールアミド、POEプロピレングリコール脂肪
酸エステル、POEアルキルアミン、POE脂肪酸アミ
ド、シ日糖脂肪酸エステル、POEノニルフェニルホル
ムアルデヒド縮金物、アルキルエトキシジメチルアミン
オキシド、トリオレイルリン酸等が挙げられる。E lauryl ether, POE oleyl ether, POE
Stearyl ether, POE behenyl ether, POE
2-octyl dodecyl ether, POE alkyl ethers such as POE cholestanol ether, POE octyl phenyl ether, POE nonylphenyl ether,
POE alkylphenyl ethers such as POE dinonylphenyl ether, Pluronic types such as Pluronic, POE-POP cetyl ether, POI!・POP
2-decyltetradecyl ether, POE-POP
Monobutyl ether, POE-POP hydrogenated lanolin,
POE-P such as POIE/POP glycerin ether
TetraPO such as OP alkyl ethers and Tetronic
E-tetra POP ethylenediamine condensates, POE castor oil, POE hydrogenated castor oil, POE hydrogenated castor oil monoisostearate, POE hydrogenated castor oil twisostearate, POE hardened castor monopyroglutamic acid monoisostearic acid diester OE hardened hardened Castor Simaleic Acid POE Castor Oil Hard Oil Superified Castor Oil Derivative OE
POE beeswax/lanolin derivatives such as sorbit beeswax, alkanolamides such as coconut oil fatty acid jetanolamide, lauric acid monoethanolamide, fatty acid isopropanolamide, POE propylene glycol fatty acid ester, POE alkylamine, POE fatty acid amide, sucrose Examples include fatty acid ester, POE nonylphenyl formaldehyde condensate, alkyl ethoxydimethylamine oxide, trioleyl phosphoric acid, and the like.
陰イオン界面活性剤としては、例えば、セッケン用素地
、ラウリン酸ナトリウム、パルミチン酸ナトリウム等の
脂肪酸センケン、ラウリル硫酸ナトリウム、ラウリル硫
酸に等の高級アルキル硫酸エステル塩、POEラウリル
硫酸トリエタノールアミン、POEラウリル硫酸ナトリ
ウム等のアルキルエーテル硫酸エステル塩、ラウロイル
サルコシンナトリうム等のN−アシルサルコシン酸、N
−ミリストイルーN−メチルタウリンナトリうム、ヤシ
油脂肪酸メチルタウリッドナトリウム、ラウリルメチル
タウリッドナトリウム等の高級脂肪酸アミドスルホン酸
塩、POF、オレイルエーテルリン酸ナトリウム、PO
Eステアリルエーテルリン酸等のリン酸エステル塩、ジ
ー2−エチルへキシルスルホコハク酸ナトリウム、モノ
ラウロイルモノエタノールアミドポリオキシエチレンス
ルホコハク酸ナトリウム、ラウリルポリプロピレングリ
コールスルホコハク酸ナトリウム等のスルホコハク酸塩
、リニアドデシルベンゼンスルホン酸ナトリウム、リニ
アドデシルベンゼンスルホン酸トリエタノールアミン、
リニアドデシルベンゼンスルホン酸等のアルキルベンゼ
ンスルホン酸塩、N−ラウロイルグルタミン酸モノナト
リウム、N−ステアロイルグルタミン酸ジナトリウム、
N−ミリストイル−L−グルタミン酸モノナトリウム等
のN−アシルグルタミン酸塩、硬化ヤシ油脂肪酸グリセ
リン硫酸ナトリうム等の高級脂肪酸エステル硫酸エステ
ル塩、ロート油等の硫酸化油、POEアルキルエーテル
カルボン酸、POEアルキルアリルエーテルカルボン酸
塩、α−オレフィンスルホン酸塩、高級脂肪酸エステル
スルホン酸塩、二級アルコール硫酸エステル塩、高級脂
肪酸アルキロールアミド硫酸エステル塩、ラウロイルモ
ノエタノールアミドコハク酸ナトリウム、N−バルミト
イルアスパラギン酸ジトリエタノールアミン、カゼイン
ナトリウム等が挙げられる。Examples of anionic surfactants include soap bases, fatty acid bases such as sodium laurate and sodium palmitate, higher alkyl sulfate salts such as sodium lauryl sulfate and lauryl sulfate, POE lauryl sulfate triethanolamine, and POE lauryl sulfate. Alkyl ether sulfate salts such as sodium sulfate, N-acyl sarcosinates such as lauroyl sarcosinate, N
- Myristoyl-N-methyltaurine sodium, higher fatty acid amide sulfonates such as coconut oil fatty acid methyltauride sodium, lauryl methyltauride sodium, POF, sodium oleyl ether phosphate, PO
Phosphate ester salts such as E-stearyl ether phosphate, sulfosuccinates such as sodium di-2-ethylhexyl sulfosuccinate, sodium monolauroyl monoethanolamide polyoxyethylene sulfosuccinate, sodium lauryl polypropylene glycol sulfosuccinate, linear dodecylbenzene sulfone acid sodium, linear dodecylbenzenesulfonic acid triethanolamine,
Alkylbenzenesulfonic acid salts such as linear dodecylbenzenesulfonic acid, monosodium N-lauroylglutamate, disodium N-stearoylglutamate,
N-acyl glutamates such as monosodium N-myristoyl-L-glutamate, higher fatty acid ester sulfate salts such as hydrogenated coconut oil fatty acid glycerol sodium sulfate, sulfated oils such as funnel oil, POE alkyl ether carboxylic acids, POE Alkyl allyl ether carboxylate, α-olefin sulfonate, higher fatty acid ester sulfonate, secondary alcohol sulfate salt, higher fatty acid alkylolamide sulfate salt, sodium lauroyl monoethanolamide succinate, N-valmitoyl Examples include ditriethanolamine aspartate and sodium caseinate.
陽イオン界面活性剤としては、例えば、塩化ステアリル
トリメチルアンモニウム、塩化ラウリルトリメチルアン
モニウJ4等のアルキルトリメチルアンモニウム塩、塩
化ジステアリルジメチルアンモニウムジアルキルジメチ
ルアンモニウム塩、塩化ポリ(N 、 N ’−ジメチ
ルー3,5−メチレンピペリジニウム)、塩化セチルピ
リジニウム等のアルキルピリジニウム塩、アルキル四級
アンモニウム塩、アルキルジメチルベンジルアンモニウ
ム塩、アルキルイソキノリニウム塩、ジアルキルモリホ
ニウム塩、POEアルキルアミン、アル:トルアミン塩
、ポリアミン脂肪酸誘導体、アミルアルコール脂肪酸誘
導体、塩化ベンザルコニウム、塩化ヘンゼトニウム、カ
チオンポリマー、アクリルる。Examples of cationic surfactants include stearyltrimethylammonium chloride, alkyltrimethylammonium salts such as lauryltrimethylammonium chloride J4, distearyldimethylammonium chloride dialkyldimethylammonium salts, and poly(N,N'-dimethyl-3,5-chloride). methylenepiperidinium), alkylpyridinium salts such as cetylpyridinium chloride, alkyl quaternary ammonium salts, alkyldimethylbenzylammonium salts, alkylisoquinolinium salts, dialkylmorphonium salts, POE alkylamines, al:toluamine salts, polyamines Fatty acid derivatives, amyl alcohol fatty acid derivatives, benzalkonium chloride, henzethonium chloride, cationic polymers, acrylics.
両面界面活性剤としては、例えば、2−ウンデシル−N
、N、N−(ヒドロキシエチルカルボキシメチル)−2
−イミダゾリニウムリうム、2−ココイル−2−イミダ
ゾリニウムヒドロキサイド−1−カルポキシエチロキシ
2ナトリウム塩等の、イミダシリン系両面界面活性剤、
2−ヘプタデシル−N−カルボキシメチル−N−ヒドロ
キシエチルイミダゾリニウムベタイン、ラウリルジメチ
ルアミノ酢酸ベタイン、アルキルベタイン、アミドベタ
イン、スルホベタイン等のベタイン系界面活性剤、N−
ラウリルβ−アラニン、N−ステアリルβ−アラニン等
のアミノ酸塩等が挙げられる。Examples of double-sided surfactants include 2-undecyl-N
, N, N-(hydroxyethylcarboxymethyl)-2
- imidacillin double-faced surfactants such as imidazolinium hydroxide, 2-cocoyl-2-imidazolinium hydroxide-1-carpoxyethyloxy disodium salt,
Betaine surfactants such as 2-heptadecyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, lauryldimethylaminoacetic acid betaine, alkylbetaine, amidobetaine, sulfobetaine, N-
Examples include amino acid salts such as lauryl β-alanine and N-stearyl β-alanine.
紫外線吸収剤としては、バラアミノ安息香酸(以下PA
R^と略す) 、PABAモノグリセリンエステル、N
、 N−ジプロポキシPAII^エチルエステル、N
、N−ジェトキシPAIIAエチルエステル、N、N−
ジメチルPABAエチルエステル、N、N−ジメチルP
ABAブチルエステル、N、N−ジメチルPABチルエ
ステル等の安息香酸系紫外線吸収剤、ホモメンチル−N
−アセチルアントラニレート等のアントラニル酸系紫外
線吸収剤、アントラニレート、メンチルサリシレート、
ホモメンチルサリシレート、オクチルサリシレート、フ
ェニルサリシレート、ペンジルサリシレート、p−イソ
プロパノールフェニルサリシレート等のサリチル酸系紫
外線吸収剤、オクチルシンナメート、エチル−4−イソ
プロピルシンナメート、メチル−2,5−ジイソプロピ
ルシンナメート、エチル−2,4−ジイソプロピルシン
ナメート、メチル−2,4−ジイソプロピルシンナメー
ト、プロピル−p−メトキシシンナメート、イソプロピ
ル−p−メトキシシンナメート、イソアミル−p−メト
キシシンナメート、オクチル−p−メトキシシンナメー
ト(2−エチルへキシル−p−メトキシシンナメート)
、2−エトキシエチル−p−メトキシシンナメート、シ
クロへキシル−p−メトキシシンナメート、エチル−α
−シアノ−β−フェニルシンナメート、2−エチルへキ
シル−α−シアノ−β−フェニルシンナメート、グリセ
リルモノ−2−エチルヘキサノイルージパラメトキシシ
ンナメート等の桂皮酸系紫外線吸収剤、2,4−ジヒド
ロキシベンゾフェノン、2.2′−ジヒドロキジ−4=
メトキシベンゾフエノン、2.2′−ジヒドロキシ−4
,4′−ジメトキシヘンシフエノン、2゜2’、4.4
’−テトラヒドロキジベンゾフェノン、2−ヒドロキシ
−4−メトキシベンゾフェノン、2−ヒドロキシ−4−
メトキシ−4′−メチルベンゾフェノン、2−ヒドロキ
シ−4−メトキシベンゾフェノン−5−スルホン酸塩、
4−フェニルベンゾフェノン、2−エチルへキシル−4
′−フェニル−ベンゾフェノン−2−カルボキシレート
、2−ヒドロキシ−4−n−オクトキシベンゾフェノン
、4−ヒドロキシ−3−カルボキシへンゾフェノン等の
ベンゾフェノン系紫外線吸収剤、3−(4’−メチルベ
ンジリデン)−d、1−カンファー、3−ベンジリデン
−d、1−カンファー、ウロカニン酸、ウロカニン酸エ
チルエステル、2−フェニル−5−メチルベンゾキサゾ
ール、2゜2′−ヒドロキシ−5−メチルフェニルベン
ゾトリアゾール、2−(2’−ヒドロキシ−5′−も−
オクチルフェニル)ベンゾトリアゾール、2−(2′−
ヒドロキシ−5′−メチルフェニルベンゾトリアゾール
、ジベンザラジン、ジアニソイルメタン、4−メトキシ
−4′−t−ブチルジベンゾイルメタン、5−(3,3
−ジメチル−2−ノルボルニリデン)−3−ペンタン−
2−オン等が挙げられる。As a UV absorber, paraaminobenzoic acid (hereinafter referred to as PA
abbreviated as R^), PABA monoglycerin ester, N
, N-dipropoxy PAII^ethyl ester, N
, N-jethoxy PAIIA ethyl ester, N, N-
Dimethyl PABA ethyl ester, N,N-dimethyl P
Benzoic acid-based UV absorbers such as ABA butyl ester, N,N-dimethyl PAB methyl ester, homomenthyl-N
- Anthranilic acid UV absorbers such as acetylanthranilate, anthranilate, menthyl salicylate,
Salicylic acid UV absorbers such as homomenthyl salicylate, octyl salicylate, phenyl salicylate, pendyl salicylate, p-isopropanol phenyl salicylate, octyl cinnamate, ethyl-4-isopropyl cinnamate, methyl-2,5-diisopropyl cinnamate, ethyl -2,4-diisopropylcinnamate, methyl-2,4-diisopropylcinnamate, propyl-p-methoxycinnamate, isopropyl-p-methoxycinnamate, isoamyl-p-methoxycinnamate, octyl-p-methoxycinnamate (2-ethylhexyl-p-methoxycinnamate)
, 2-ethoxyethyl-p-methoxycinnamate, cyclohexyl-p-methoxycinnamate, ethyl-α
-Cinnamic acid UV absorbers such as cyano-β-phenylcinnamate, 2-ethylhexyl-α-cyano-β-phenylcinnamate, glyceryl mono-2-ethylhexanoyl dip-paramethoxycinnamate, 2,4 -dihydroxybenzophenone, 2.2'-dihydroxydi-4=
Methoxybenzophenone, 2,2'-dihydroxy-4
, 4'-dimethoxyhensiphenone, 2°2', 4.4
'-Tetrahydrokidibenzophenone, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-
Methoxy-4'-methylbenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonate,
4-phenylbenzophenone, 2-ethylhexyl-4
Benzophenone ultraviolet absorbers such as '-phenyl-benzophenone-2-carboxylate, 2-hydroxy-4-n-octoxybenzophenone, 4-hydroxy-3-carboxyhenzophenone, 3-(4'-methylbenzylidene)- d, 1-camphor, 3-benzylidene-d, 1-camphor, urocanic acid, urocanic acid ethyl ester, 2-phenyl-5-methylbenzoxazole, 2゜2'-hydroxy-5-methylphenylbenzotriazole, 2 -(2'-hydroxy-5'- also-
octylphenyl)benzotriazole, 2-(2'-
Hydroxy-5'-methylphenylbenzotriazole, dibenzaladine, dianisoylmethane, 4-methoxy-4'-t-butyldibenzoylmethane, 5-(3,3
-dimethyl-2-norbornylidene)-3-pentane-
2-one etc. are mentioned.
粘土鉱物としては、例えばモンモリロナイト、ザコウナ
イト、ノントロナイト、サポナイト、ヘクトライト、バ
ーミキュライト、ビーガム、ベントナイト、シリケイト
、フルオロシリケイト、マグネシウム、アルミニウム、
合成へクトライト(ラポナイト)等の天然及び合成水膨
潤性の粘土鉱物等が挙げられる。Examples of clay minerals include montmorillonite, zakounite, nontronite, saponite, hectorite, vermiculite, vegum, bentonite, silicate, fluorosilicate, magnesium, aluminum,
Examples include natural and synthetic water-swellable clay minerals such as synthetic hectorite (laponite).
アミノ酸として、例えばグリシン、アラニン、バリン、
ロイシン、イソロイシン、セリン、トレオニン、フェニ
ルアラニン、チロシン、トリプトファン、シスチン、シ
スティン、メチオニン、プロリン、ヒドロキシプロリン
、■、−11opa等の中性アミノ酸、アスパラギン酸
、グルタミン酸、アスパラギン、グルタミン等の酸性ア
ミノ酸、およびアラギニン、ヒスチジン、リジン等の塩
基性アミノ酸が挙げられる。また、アミノ酸誘導体とし
て、例えばアシルサルコシンナトリウム(ラウロイルサ
ルコシンナトリウム)、アシルグルタミン酸塩、アシル
β−アラニンナトリウム、グルタチオン、ピロリドンカ
ルボン酸等が挙げられる。Examples of amino acids include glycine, alanine, valine,
Neutral amino acids such as leucine, isoleucine, serine, threonine, phenylalanine, tyrosine, tryptophan, cystine, cysteine, methionine, proline, hydroxyproline, -11 opa, acidic amino acids such as aspartic acid, glutamic acid, asparagine, glutamine, and araginine. , histidine, lysine, and other basic amino acids. Further, examples of amino acid derivatives include sodium acylsarcosine (sodium lauroylsarcosine), acylglutamate, sodium acyl β-alanine, glutathione, and pyrrolidone carboxylic acid.
天然の水溶性高分子としては例えば、アラビアガム、ト
ラガカントガム、ガラクタン、グアガム、キャロブガム
、カラヤガム、カラギーナン、ペクチン、カンテン、ク
インスシード(マルメロ)、アルゲコロイド(カッソウ
エキス)、デンプン(コメ、トウモロコシ、バレイショ
、コムギ)、グリチルリチン酸等の植物系高分子、キサ
ンタンガム、デキストラン、サクシノグルカン、プルラ
ン等の微生物系高分子、コラーゲン、カゼイン、アルブ
ミン、ゼラチン等の動物系高分子が挙げられる。Examples of natural water-soluble polymers include gum arabic, gum tragacanth, galactan, guar gum, carob gum, gum karaya, carrageenan, pectin, agar, quince seed (quince), algae colloid (cassava extract), starch (rice, corn, potato, wheat). ), plant polymers such as glycyrrhizic acid, microbial polymers such as xanthan gum, dextran, succinoglucan, pullulan, and animal polymers such as collagen, casein, albumin, and gelatin.
半合成の水溶性高分子としては、例えば、カルボキシメ
チルデンプン、メチルヒドロキシプロピルデンプン等の
デンプン系高分子、メチルセルロース、ニトロセルロー
ス、エチルセルロース、メチルヒドロキシプロピルセル
ロース、ヒドロキシエチルセルロース、セルロース硫酸
ナトリウム、ヒドロキシプロピルセルロース、カルボキ
シメチルセルロースナトリウム(CMC)、結晶セルロ
ース、セルロース末等のセルロース系高分子、アルギン
酸ナトリウム、アルギン酸プロピレングリコールエステ
ル等のアルギン酸系高分子が挙げられる。Examples of semi-synthetic water-soluble polymers include starch-based polymers such as carboxymethyl starch and methylhydroxypropyl starch, methylcellulose, nitrocellulose, ethylcellulose, methylhydroxypropylcellulose, hydroxyethylcellulose, sodium cellulose sulfate, hydroxypropylcellulose, Examples include cellulose polymers such as sodium carboxymethyl cellulose (CMC), crystalline cellulose, and cellulose powder, and alginic acid polymers such as sodium alginate and propylene glycol alginate ester.
合成の水溶性高分子としては例えば、ポリビニルアルコ
ール、ポリビニルメチルエーテル、ポリビニルピロリド
ン、カルボキシビニルポリマー(カーボボール)等のビ
ニル系高分子、ポリエチレングリコ−ル20.000.
4,000,000.600,000等子、ポリアクリ
ル酸ナトリウム、ポリエチルアクリレート、ポリアクリ
ルアミド等のアクリル系高分子、ポリエチレンイミン、
カチオンポリマー等が挙げられる。Examples of synthetic water-soluble polymers include vinyl polymers such as polyvinyl alcohol, polyvinyl methyl ether, polyvinylpyrrolidone, carboxyvinyl polymer (Carbobol), and polyethylene glycol 20.000.
4,000,000.600,000 isomers, acrylic polymers such as sodium polyacrylate, polyethyl acrylate, and polyacrylamide, polyethyleneimine,
Examples include cationic polymers.
無機の水溶性高分子としては例えば、ベントナイト、ケ
イ酸AlMg (ビーガム)、ラポナイト、ヘクトライ
ト、無水ケイ酸等が挙げられる。Examples of inorganic water-soluble polymers include bentonite, AlMg silicate (vegum), laponite, hectorite, and silicic anhydride.
保湿側としては、例えばポリエチレングリコール、プロ
ピレングリコール、グリセリン、1,3−ブチレングリ
コール、キシリトール、ソルビトール、マルチトール、
コンドロイチン硫酸、ヒアルロン酸、ムコイチン硫酸、
カロニン酸、アテロコラーゲン、コレステリル−12−
ヒドロキシステアレート、乳酸ナトリウム、胆汁酸塩、
dl−ピロリドンカルボン酸塩、短鎖可溶性コラーゲン
、ジグリセリン(EO) PO付加物等が挙げられる。On the moisturizing side, for example, polyethylene glycol, propylene glycol, glycerin, 1,3-butylene glycol, xylitol, sorbitol, maltitol,
chondroitin sulfate, hyaluronic acid, mucoitin sulfate,
caronic acid, atelocollagen, cholesteryl-12-
Hydroxystearate, sodium lactate, bile salts,
Examples include dl-pyrrolidone carboxylate, short chain soluble collagen, diglycerin (EO) PO adduct, and the like.
多価アルコールとしては、例えば、エチレングリコール
、プロピレングリコール、トリメチレングリコール、1
,2−ブチレングリコール、1゜3−ブチレンゲルコー
ル、テトラメチレンゲルコール、2.3−ブチレンゲル
コール、ペンタメチレングルニ1−ル、2−フ゛テンー
1.4−ジーt−ル、ヘキシレングリコール、オクチレ
ングリコール等の2価のアルコール、グリセリン、トリ
メチロールプロパン、1,2.6−ヘキサントリオール
等の3価のアルコール、ペンタエリスリトール等の4価
のアルコール、キシリトール等の5価のアルコール、ソ
ルビトール、マンニトール等の6価のアルコール、ジエ
チレングリコール、ジプロピレングリコール、l・ジエ
チレングリコール、ポリプロピレングリコール、テトラ
エチレングリコール、ジグリセリン、ポリエチレングリ
コール、トリグリセリン、テトラグリセリン、ポリグリ
セリン等の多価アルコール重合体、エチレングリコール
モノメチルエーテル、エチレングリコールモノエチルエ
ーテル、エチレングリコールモノブチルエーテル、エチ
レングリコールモノフェニルエーテル、エチレングリコ
ールモノへキシルアコ−ル、エチレングリコールモノ2
−メチルヘキシルエーテル、エチレングリコールイソア
ミルエーテル、エチレングリコールベンジルエーテル、
エチレングリコールイソプロピルエーテル、エチレング
リコールジメチルエーテル、エチレングリコールジエチ
ルエーテル、エチレングリコールジブチルエーテル等の
2価のアルコールアルキルエーテル類、ジエチレングリ
コールモノブチルエーテル、ジエチレングリコールモノ
エチルエーテル、ジエチレングリコールモノブチルエー
テル、ジエチレングリコールジメチルエーテル、ジエチ
レングリコールジエチルエーテル、ジエチレングリコー
ルブチルエーテル、ジエチレングリコールメチルエチル
エーテル、トリエチレングリコールモノメチルエーテル
、トリエチレングリコールモノエチルエーテル、プロピ
レングリコールモノメチルエーテル、プロピレングリコ
ールモノエチルエーテル、プロピレングリコールモノブ
チルエーテル、プロピレングリコールイソプロピルエー
テル、ジプロピレングリコールメチルエーテル、ジプロ
ピレングリコールエチルエーテル、ジプロピレングリコ
ールブチルエーテル等の2価アルコールアルキルエーテ
ル類、エチレングリコール千ツメチルエーテルアセテー
ト、エチレングリコールモノエチルエーテルアセテート
、エチレングリコールモノブチルエーテルアセテート、
エチレングリコールモノフェニルエーテルアセテート、
エチレングリコールジアジヘート、エチレングリコール
ジサクシネート、ジエチレングリコールモノエチルエー
テルアステート、ジエチレングリコール千ノブチルエー
テルアセテ−1−、プロピレングリコールモノメチルエ
ーテルアセテ−1〜、プロピレングリコールモノエチル
エーテルアセテート、プロピレングリコールモノプロビ
ルエーテルアセテート、プロピレングリコールモノフェ
ニルエーテルアセテート等の2価アルコールエーテルエ
ステル、キシルアルコール、セラキルアルコール、バチ
ルアルコール等のグリセリンモノアルキルエーテル、ソ
ルビトール、マルチトール、マルトトリオース、マンニ
トール、ショ糖、エリトリトール、グルコース、フルク
ト−ス、デンプン分解糖、マルトース、キシリl−−ス
、デンプン分解糖還元アルコール等の糖アルコール、グ
リソリッド、テトラハイドロフルフリルエーテル
リセリンエーテルリン酸、POP POIEペンタンエ
リスリトールエーテル等が挙げられる。Examples of polyhydric alcohols include ethylene glycol, propylene glycol, trimethylene glycol,
, 2-butylene glycol, 1゜3-butylene gelcol, tetramethylene gelcol, 2,3-butylene gelcol, pentamethylene glycol, 2-butylene-1,4-di-tyl, hexylene glycol , dihydric alcohols such as octylene glycol, trihydric alcohols such as glycerin, trimethylolpropane, 1,2,6-hexanetriol, tetrahydric alcohols such as pentaerythritol, pentahydric alcohols such as xylitol, sorbitol. , hexahydric alcohols such as mannitol, polyhydric alcohol polymers such as diethylene glycol, dipropylene glycol, l-diethylene glycol, polypropylene glycol, tetraethylene glycol, diglycerin, polyethylene glycol, triglycerin, tetraglycerin, polyglycerin, ethylene glycol Monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, ethylene glycol monophenyl ether, ethylene glycol monohexyl alcohol, ethylene glycol mono2
- methylhexyl ether, ethylene glycol isoamyl ether, ethylene glycol benzyl ether,
Divalent alcohol alkyl ethers such as ethylene glycol isopropyl ether, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol dibutyl ether, diethylene glycol monobutyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol butyl ether , diethylene glycol methyl ethyl ether, triethylene glycol monomethyl ether, triethylene glycol monoethyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monobutyl ether, propylene glycol isopropyl ether, dipropylene glycol methyl ether, dipropylene glycol ethyl Ether, dihydric alcohol alkyl ethers such as dipropylene glycol butyl ether, ethylene glycol methyl ether acetate, ethylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether acetate,
ethylene glycol monophenyl ether acetate,
Ethylene glycol diadihate, ethylene glycol disuccinate, diethylene glycol monoethyl ether astate, diethylene glycol 1,000 butyl ether acetate-1-, propylene glycol monomethyl ether acetate-1-, propylene glycol monoethyl ether acetate, propylene glycol monopropyl ether acetate, dihydric alcohol ether esters such as propylene glycol monophenyl ether acetate, glycerin monoalkyl ethers such as xyl alcohol, serakyl alcohol, batyl alcohol, sorbitol, maltitol, maltotriose, mannitol, sucrose, erythritol, glucose, Sugar alcohols such as fructose, starch decomposing sugar, maltose, xylyl--s, starch decomposing sugar reducing alcohol, glycolide, tetrahydrofurfuryl ether lycerin ether phosphate, POP POIE pentane erythritol ether, and the like.
増粘剤としては、例えばアラビアガム、カラギーナン、
カラヤガム、トラガカントガム、キャロブガム、クイン
スシード(マルメロ)、カゼイン、デキストリン、ゼラ
チン、ペクチン酸ナトリウム、アラギン酸ナトリウム、
メチルセルロース、エチルセルロース、CMC,ヒドロ
キシエチルセルロース、ヒドロキシプロピルセルロース
、PVA,PVM。Examples of thickeners include gum arabic, carrageenan,
Karaya gum, tragacanth gum, carob gum, quince seed (quince), casein, dextrin, gelatin, sodium pectate, sodium alaginate,
Methyl cellulose, ethyl cellulose, CMC, hydroxyethyl cellulose, hydroxypropyl cellulose, PVA, PVM.
pvp,ポリアクリル酸ナトリうム、カルボキシビニル
ポリマー、ローカストビーンガム、グアーガム、タマリ
ンドガム、ジアルキルジメチルアンモニラ1、硫酸セル
ロース、キサンタンガム、ケイ酸AIMgヘントナイト
、ヘクトライト等が挙げられる。Examples include pvp, sodium polyacrylate, carboxyvinyl polymer, locust bean gum, guar gum, tamarind gum, dialkyldimethylammonyl 1, cellulose sulfate, xanthan gum, silicate AIMghentonite, and hectorite.
油分としては、例えばアボガド油、ツバキ油、タードル
油、マカデミアナツツ油、トウモロコシ油、ミンク油、
オリーブ油、ナタネ油、卵黄油、ゴマ油、パーシック油
、小麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフ
ラワー油、綿実油、エノ油、大豆油、落花生油、茶実油
、カヤ油、コメヌカ油、シナキリ油、日本キリ油、ホホ
バ油、胚芽油、トリグリセリン、トリオクタン酸グリセ
リン、トリイソパルミチン酸グリセリン等の液体油脂、
カカオ脂、ヤシ油、馬脂、硬化ヤシ油、パーム油、牛脂
、羊脂、硬化牛脂、パーム核油、肝脂、牛骨脂、モクロ
ウ核油、硬化油、牛脚脂、モクロウ、硬化ヒマシ油等の
固体油脂、ミツロウ、カンデリラロウ、綿ロウ、カルナ
ウバロウ、ペイベリーロウ、イボタロウ、鯨ロウ、モン
クンロウ、ヌカロウ、ラノリン、カポックロウ、酢酸ラ
ノリン、液イにラノリン、サトウキビロウ、ラノリン脂
肪酸イソプロピル、ラウリン酸ヘキシル、還元ラノリン
、ジョジョハロウ、硬質ラノリン、セラソクロつ、PO
Eラノリンアルコールエーテル、POEラノリンアルコ
ールアセテート、POEコレステロールエーテル、ラノ
リン脂肪酸ポリエチレングリコール、POE水素添加ラ
ノリンアルコールエーテル等のロウ類、流動パラフィン
、オシケライト、スクワレン、プリスタン、パラフィン
、セレシン、スクワラン、ワセリン、マイクロクリスタ
リンワックス等の炭化水素が挙げられる。Examples of oil include avocado oil, camellia oil, turdle oil, macadamia nut oil, corn oil, mink oil,
Olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, linseed oil, safflower oil, cottonseed oil, eno oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil , liquid oils and fats such as Shinakiri oil, Japanese tung oil, jojoba oil, germ oil, triglycerin, glycerin trioctanoate, glycerin triisopalmitate,
Cocoa butter, coconut oil, horse tallow, hydrogenated coconut oil, palm oil, beef tallow, mutton tallow, hydrogenated beef tallow, palm kernel oil, liver fat, beef bone tallow, Japanese oak kernel oil, hydrogenated oil, beef leg tallow, Japanese oak, hydrogenated castor Solid fats and oils such as oil, beeswax, candelilla wax, cotton wax, carnauba wax, paiberry wax, privet wax, spermaceti wax, monk wax, bran wax, lanolin, kapok wax, lanolin acetate, liquid lanolin, sugar cane wax, lanolin fatty acid isopropyl, hexyl laurate, reduction Lanolin, Jojo Hallow, Hard Lanolin, Sera Sokurotsu, PO
Waxes such as E lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, POE hydrogenated lanolin alcohol ether, liquid paraffin, osikelite, squalene, pristane, paraffin, ceresin, squalane, petrolatum, microcrystalline wax Hydrocarbons such as
シリコン化合物としては、例えば、ジメチルポリシロキ
サン、メチルフェニルポリシロキサン、メチルハイドロ
ジエンポリシロキサン等の鎖状ポリシロキサン、デカメ
チルポリシロキサン、ドデカメチルポリシロキサン、テ
トラメチルテトラハシリコーン樹脂およびシリコーンゴ
ム等が挙げられる。Examples of silicon compounds include linear polysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, and methylhydrodienepolysiloxane, decamethylpolysiloxane, dodecamethylpolysiloxane, tetramethyltetrasilicone resin, and silicone rubber. It will be done.
本発明の皮膚外用剤の剤型は任意であり、例えば化粧水
等の可溶化系、乳液、クリーム等の乳化系、あるいは軟
膏、分散液などの剤型をとることができる。The formulation for external use on the skin of the present invention can be in any form, for example, a solubilized type such as a lotion, an emulsified type such as a milky lotion, a cream, an ointment, a dispersion, and the like.
次に実施例によって本発明をさらに詳細に説明する。な
お本発明はこれにより限定されるものではない。Next, the present invention will be explained in more detail with reference to Examples. Note that the present invention is not limited to this.
例−1−二c、 D N Aの一作−製(1)ニワトリ
の15日卵50個より心臓周辺の大動脈を分離し、液体
窒素で破砕した後、グアニジウムチオシアネート水溶液
を添加し、ホモジナイズした。得られたホモジネートを
Chirgwinらの方法(Chirgwin等、Bi
ochem、18,5294.1979)に従って塩化
セシウム平衡密度勾配超遠心分離することにより、RN
Aを分離した。オリゴdTセルロース(ファルマシア社
製、タイプ7)を担持するアフィニティークロマトグラ
フィーにより、前記RNA分画からポリAを持つポリA
” RNAを単離した。Example-1-2c, Preparation of DNA (1) The aorta around the heart was separated from 50 15-day-old chicken eggs, crushed with liquid nitrogen, and then homogenized by adding an aqueous solution of guanidium thiocyanate. did. The obtained homogenate was subjected to the method of Chirgwin et al.
RN by cesium chloride equilibrium density gradient ultracentrifugation according to Ochem, 18, 5294.1979).
A was isolated. Poly A containing poly A was extracted from the RNA fraction by affinity chromatography supporting oligo dT cellulose (manufactured by Pharmacia, Type 7).
” RNA was isolated.
(2)市販の岡山−バーブのベクターを用いたcDNA
クローニングシステム(アマジャム社製)によりcDN
Aライブラリーを作製した。(2) cDNA using commercially available Okayama-Barb vector
cDNA by cloning system (manufactured by Amajam)
A library was created.
すなわち、トリス塩酸緩衝液(pl+ 8.3 ) 、
塩化マグネシウム、塩化カリウム、ジチオスレイトール
、dATP 、dGTP 、dTTP及びα−32pd
CTPを含む水溶液に、上記(1)で得られたポリA″
RNA約10μgと岡山−ハーグのベクタープライマー
約5μgとを加え、逆転写酵素(生化学工業社製)の存
在下で、37℃で30分間逆転写反応を行なった。合成
されたcDNAを含むベクタープラスミドをエタノール
沈澱により回収した。この沈澱を乾燥した後、トリス塩
酸緩衝液(pH6、9) 、カコジル酸ナトリウム、塩
化コバルト、ジチオスレイトール、ウシ血清アルブミン
及びα−”PdCTPを含む水溶液に溶解し、ウシ胸腺
由来のターミナルデオキシヌクレオチジルトランスフェ
ラーゼを添加し、37℃で30分間反応させ、末端あた
り約15〜30残基のオリゴシトシンをcDNAに付加
した。得られたcDNA含有ベクターを制限酵素旧nd
l[Iで消化した後、エタノール沈澱により、オリゴシ
トシン付加cDNA含有ヘククーを回収した。That is, Tris-HCl buffer (pl+ 8.3),
Magnesium chloride, potassium chloride, dithiothreitol, dATP, dGTP, dTTP and α-32pd
Add polyA'' obtained in (1) above to an aqueous solution containing CTP.
About 10 μg of RNA and about 5 μg of Okayama-Hague vector primer were added, and a reverse transcription reaction was performed at 37° C. for 30 minutes in the presence of reverse transcriptase (manufactured by Seikagaku Corporation). The vector plasmid containing the synthesized cDNA was recovered by ethanol precipitation. After drying this precipitate, it was dissolved in an aqueous solution containing Tris-HCl buffer (pH 6, 9), sodium cacodylate, cobalt chloride, dithiothreitol, bovine serum albumin, and α-''PdCTP, and the terminal deoxynucleotide derived from bovine thymus was dissolved. Dyltransferase was added and reacted at 37°C for 30 minutes to add about 15 to 30 oligocytosine residues per end to the cDNA.The resulting cDNA-containing vector was digested with restriction enzymes
After digestion with l[I, heku-ku containing oligocytosine-added cDNA was recovered by ethanol precipitation.
市販のオリゴdGテールリンカ−DNAを含む緩衝液(
トリス塩酸pl+8.0、塩化マグネシウム、IEDT
A、NAI’)、硫酸アンモニウムを含む)に上記オリ
ゴシトシン付加cDNA含有ベクターを溶解し、大腸菌
DNAリガーゼを加えて、16℃で15時間反応させた
。その後、dATP、dCTP 、dGTP 、dTT
P 、NAD、大腸菌DNAリガーゼ、大腸菌DNAポ
リメラーゼ、大腸菌RNa5e Hを加え、室温で1時
間反応させ、cDNA含有プラスミドを得た。Buffer containing commercially available oligo dG tail linker DNA (
Tris hydrochloric acid pl+8.0, magnesium chloride, IEDT
The oligocytosine-added cDNA-containing vector was dissolved in A, NAI') containing ammonium sulfate, E. coli DNA ligase was added, and the mixture was reacted at 16°C for 15 hours. Then dATP, dCTP, dGTP, dTT
P, NAD, E. coli DNA ligase, E. coli DNA polymerase, and E. coli RNA5e H were added and reacted for 1 hour at room temperature to obtain a cDNA-containing plasmid.
得られたプラスミドを用い、塩化カルシウム法(Man
rlel等、J、Mo14io1.53.159.19
70)に従って、大腸菌M2S株を形質転換し、アンピ
シリン30μg / m りを含むL B培地で生育す
るアンピシリン耐性株を取得した。Using the obtained plasmid, the calcium chloride method (Man
rl et al., J. Mo14io1.53.159.19
70), E. coli M2S strain was transformed to obtain an ampicillin-resistant strain that grew in LB medium containing 30 μg/m of ampicillin.
(3)上記(1)に示した方法と同様にして、ニワトリ
の15日卯の皮膚組織からポリA” RNAを単離した
。このポリA″RNAと上記(1)で得られたポリA”
RNAとを、それぞれ、pl+8.0のトリス塩酸緩
衝液中で大腸菌アルカリフォスファターゼ処理(25℃
1時間)して5′末端のリン酸をはずし、酵素を失活さ
せた後、T4ポリヌクレオチドキナーゼと、γ−”P−
ATPとを添加し、1時間37℃でリン酸化反応をし、
32pラベルポリA″RNA (プローブ)を得た。(3) Poly A'' RNA was isolated from the skin tissue of a 15-day old chicken using the same method as described in (1) above. This poly A'' RNA and the poly A'' RNA obtained in (1) above were isolated. ”
RNA and E. coli alkaline phosphatase treatment (25°C) in Tris-HCl buffer at pl+8.0.
1 hour) to remove the 5'-terminal phosphate and inactivate the enzyme. Then, T4 polynucleotide kinase and γ-"P-
ATP was added and the phosphorylation reaction was carried out at 37°C for 1 hour.
32p labeled poly A'' RNA (probe) was obtained.
(4)上記(3)で得られたプローブを用いて、上記(
2)で得られた形質転換株について、Hanahanら
の方法(Hanahan D、等、Gene、 10.
63.1980)に従ってコロニーハイブリダイゼーシ
ョンを行なった。(4) Using the probe obtained in (3) above,
Regarding the transformed strain obtained in 2), the method of Hanahan et al. (Hanahan D, et al., Gene, 10.
Colony hybridization was performed according to 63.1980).
大動脈由来のプローブに相補性を示し、しかも皮膚由来
のプローブに相補性を示さないコロニーを選択したとこ
ろ、1000コロニーのうち6個のクローンが得られた
。これらのクローンからプラスミドDNAを抽出し、制
限酵素Pvorlによる制限酵素地図を作成したところ
、3つのクローンについては、共通のDNA断片が見ら
れた。この共通のDNA断片をもつCDNAについて、
M13mp11ファージを用いたジデオキシヌクレオチ
ド酵素法(Messing、J、Method in
Enzymo1ogy+Vol、lo1+P2O,Ac
ademic Press、1983)に従ってDNA
塩基配列を決定した。こうして決定したcDNAの塩基
配列及びそれより想定されるアミノ酸配列を第1図に示
した。第1図に示すアミノ酸配列中には、エラスチン特
有のアミノ酸配列として知られているβ−シート構造を
形成するペンタペプチド(Val−Pro−Gly−V
at−Gly;第1図で下線を付けて示す)及び架橋形
成周辺配列(第1図で箱で囲んで示す)がそれぞれ複数
存在した。従って、得られたcDNAがトロポエラスチ
ンのcDNAであることを示していた。Colonies showing complementarity to the aorta-derived probe but not to the skin-derived probe were selected, and 6 clones out of 1000 colonies were obtained. When plasmid DNA was extracted from these clones and a restriction enzyme map was created using the restriction enzyme Pvorl, a common DNA fragment was found among the three clones. Regarding CDNA with this common DNA fragment,
Dideoxynucleotide enzymatic method using M13mp11 phage (Messing, J., Method in
Enzymo1ogy+Vol, lo1+P2O, Ac
DNA according to Academic Press, 1983)
The base sequence was determined. The base sequence of the cDNA thus determined and the amino acid sequence deduced from it are shown in FIG. The amino acid sequence shown in Figure 1 contains a pentapeptide (Val-Pro-Gly-V
There were multiple at-Gly; underlined in FIG. 1) and multiple crosslinking peripheral sequences (boxed in FIG. 1). Therefore, it was shown that the obtained cDNA was that of tropoelastin.
本例では、tacプロモーターとrrnBのターミネー
タ−とを用いたpKK223−3発現ベクター(ファル
マシア社製)を使用してトロポエラスチン発現ベクター
を作製した(第2図参照)。In this example, a tropoelastin expression vector was constructed using a pKK223-3 expression vector (manufactured by Pharmacia) that uses a tac promoter and an rrnB terminator (see FIG. 2).
(1)前記例1で作製したエラスチンcDNAをクロー
ニングした岡山−バーブのベクターρE1,2がら、ト
ロポエラスチン蛋白質をコードするcDNA部分を切り
出した。pE12のDNA約10ngをH4nd mで
消化し、さらにBa131を用いて部分消化した。37
℃で5分間反応させたところ、平均約300bpが消化
されていた。このl”)NAをT4DNAポリメラーゼ
ラージフラグメント処理し、C1alリンカ−(pCA
TCGATG)をT4DNAリガーゼにより結合させた
。得られたDNA断片をm−制限酵素部位であるNde
lおよびC1alで消化し、1%アガロースゲル(シグ
マ社製タイプ■)で電気泳動を行ない、約1,5kbr
)NA断片を70℃で抽出し、エタノール沈澱して単離
した。(1) The cDNA portion encoding the tropoelastin protein was excised from the Okayama-Barb vector ρE1,2 into which the elastin cDNA prepared in Example 1 was cloned. Approximately 10 ng of pE12 DNA was digested with H4nd m and further partially digested with Ba131. 37
When reacted at ℃ for 5 minutes, an average of about 300 bp was digested. This l'')NA was treated with T4 DNA polymerase large fragment, and C1al linker (pCA
TCGATG) was ligated with T4 DNA ligase. The obtained DNA fragment was inserted into the m-restriction enzyme site Nde.
Digested with 1 and C1al, and electrophoresed on 1% agarose gel (Sigma type ■) to obtain approximately 1.5 kbr.
) NA fragments were extracted at 70°C and isolated by ethanol precipitation.
(2) pBR322(約5ng)のBamH1部位を
Charに変換したプラスミドを作製し、このプラスミ
ドをC1aIおよびNdelで消化し、1%アガロース
ゲル電気泳動により1.9 k bのDNA断片を(1
)と同様に単離した。(2) A plasmid was prepared by converting the BamH1 site of pBR322 (approximately 5 ng) to Char, this plasmid was digested with C1aI and Ndel, and a 1.9 kb DNA fragment was separated by 1% agarose gel electrophoresis (1
) was isolated in the same manner.
(3)前記(1)及び(2)で得られたr)NA断片を
、T4DNAポリメラーゼで結合させ、カルシウム処理
法(Mandel等、J、Mo1.Riol、53.1
59゜1970)を用いて大腸菌に12株JM]05に
導入しく42)
た。30μg7m7!のアンピシリンを含むI−Bプレ
ート(1%トリプトン、0.5%酵母エキス、1%Na
CI)で生育する形質転換株を得た。得られた形質転換
株からアルカリ抽出法(Birnboim等、Nucl
、八c、’+d Ros、7,1513.1979)に
よりプラスミドDNApEI、12を抽出した。(3) The r) NA fragments obtained in (1) and (2) above were combined with T4 DNA polymerase, and the calcium treatment method (Mandel et al., J, Mo1. Riol, 53.1
59゜1970) was used to introduce 12 strains of E. coli into E. coli JM]05 [42]. 30μg7m7! I-B plates containing ampicillin (1% tryptone, 0.5% yeast extract, 1% Na
A transformed strain that grows in CI) was obtained. The obtained transformed strain was subjected to alkaline extraction method (Birnboim et al., Nucl.
, 8c,'+d Ros, 7, 1513.1979) to extract plasmid DNA pEI, 12.
(4) pEl、12から1lind Iff −P
vu II断片を単離し、M13mplO(アマジャム
社製)の旧ndlll −3mar部位にサブクローニ
ングした。この1本鎖DNAを用いてジデオキシヌクレ
オチド酵素法(Messing 、 Method i
n Enzymology、シof、101.p20゜
Academic Press、1983)に従ってD
NA塩基配列を決定した。(4) pEl, 12 to 1lind If -P
The vu II fragment was isolated and subcloned into the old ndllll-3mar site of M13mplO (manufactured by Amajam). This single-stranded DNA was used to perform the dideoxynucleotide enzymatic method (Messing, Method i).
n Enzymology, of, 101. D according to p. 20° Academic Press, 1983)
The NA base sequence was determined.
(5) pEl、12においてBa131で部分消化さ
れた部位(Clar部位)は、cDNAの多くの部位に
位置しており第1図の5′末端にC1alリンカ−が結
合し、CATCG −ATG −GTC−GGT−Me
t Val Gly
・・・表結合したものも得られた(pEL12−A)。(5) The site partially digested with Ba131 in pEl, 12 (Clar site) is located at many sites in the cDNA, and a C1al linker is attached to the 5' end of the cDNA as shown in Figure 1, resulting in CATCG-ATG-GTC. -GGT-Me
t Val Gly ... A table-bound version was also obtained (pEL12-A).
(6) pEl、12−へのCIaIおよびNdel断
片を得、pKK223−3のEcoRT部位にブラン1
エンFライゼーシヨンで挿入した〔操作は前記(1)〜
(3)と同様に行った〕。(3)と同様に形質転換し、
DNAを抽出した後、tacプロモーター下流に転写方
向のCDNAが結合したプラスミドル旧、22を得た。(6) Obtain the CIaI and Ndel fragments into pEl, 12- and insert blank 1 into the EcoRT site of pKK223-3.
Inserted with enF Rization [operations are from (1) above]
(3)] Transform in the same manner as (3),
After extracting the DNA, plasmid plasmid 22 in which cDNA in the transcriptional direction was bound downstream of the tac promoter was obtained.
(7)得られた形質転換株を30μg/m7!のアンピ
シリン及び1mMTPTGを含む1. r3培地500
mA’に植菌し、30℃で24時間振とぅ培養した。培
養後、遠心分離により菌体を集菌し、lom/の緩衝液
(50mMトリス塩酸pH7,5、50mMEDT八、
1mMへ−メルカプトエタノールし、Sonifier
超音波ホモジナイザー(プランソン社製)で、4℃で1
5分間処理し、細胞砕壊後、遠心分離により上清液を得
た。(7) 30μg/m7 of the obtained transformed strain! 1. containing ampicillin and 1mM TPTG. r3 medium 500
mA' was inoculated and cultured with shaking at 30°C for 24 hours. After culturing, the bacterial cells were collected by centrifugation and added to a LOM buffer solution (50mM Tris-HCl pH 7.5, 50mM EDT8,
-Mercaptoethanol to 1mM and Sonifier
1 at 4℃ using an ultrasonic homogenizer (manufactured by Planson).
After treatment for 5 minutes to disrupt the cells, a supernatant was obtained by centrifugation.
(8)一方、トロポエラスチンのアミノ酸配列の一部で
あるデカペプチドPro−A Ia − A Ia −
A Ia− Ala − Lys−Ala − A
la − Ala − Lysをペプチドシンセサイザ
ーモデル430A (アブライトバイオシステムズ社製
)により化学合成し、Kaganらの方法(A.Kag
an等、Tn Methods of llormon
eRadioimmunoassay, B.M.Ja
ffeおよびIl.R.Behyman編、p328
Academjc Press,1979)により、グ
ルタルアルデヒドを用いて、BSA (ウシ血清アルブ
ミン) 1分子あたり約10分子のデカペプチドを結合
させた。このBSA誘導体I Qmgを20週間で10
回に分けて白色雄性家兎の皮下に注射した。抗体が産生
じていることを抗原抗体反応により確認した後、血液を
取得し、常法により抗血清を得た。(8) On the other hand, the decapeptide Pro-A Ia-A Ia- which is part of the amino acid sequence of tropoelastin
A Ia-Ala-Lys-Ala-A
la-Ala-Lys was chemically synthesized using Peptide Synthesizer Model 430A (manufactured by Abrite Biosystems), and the method of Kagan et al.
an et al., Tn Methods of llormon
eRadioimmunoassay, B. M. Ja
ffe and Il. R. Edited by Behyman, p328
Academjc Press, 1979), about 10 molecules of decapeptide were bound to each molecule of BSA (bovine serum albumin) using glutaraldehyde. 10 mg of this BSA derivative I in 20 weeks.
It was injected subcutaneously into white male rabbits in divided doses. After confirming that antibodies were produced by antigen-antibody reaction, blood was obtained and antiserum was obtained by a conventional method.
(9)前記(7)で得た上清をセファデックスG−10
0カラムクロマトグラフイーで処理し、前記(8)で作
製した抗体に反応する分画を得た。この分画を限外濾過
により濃縮し、FPLC (ファルマシア社製) Mo
noQカラ1、を用いた高速液体クロマトグラフィーに
より精製し、抗体に反応する分画を得た。この分画を凍
結乾燥してトロポエラスチンを得た。(9) Transfer the supernatant obtained in (7) above to Sephadex G-10.
0 column chromatography to obtain a fraction that reacts with the antibody prepared in (8) above. This fraction was concentrated by ultrafiltration and subjected to FPLC (manufactured by Pharmacia) Mo
It was purified by high performance liquid chromatography using noQ Color 1 to obtain a fraction that reacts with the antibody. This fraction was freeze-dried to obtain tropoelastin.
(10)得られたトロポエラスチンはSDSポリアクリ
ルアミドゲル電気泳動で単一バンドであり、分子量約3
0000ダルトンであった。さらに、工1゛マン分解に
よりN末端を決定したところVal −G)y − V
al − Pro−Gayの配列であることが確認され
、目的とするトロポエラスチンが大腸菌により生産され
ていることを確認するこ吉ができた。(10) The obtained tropoelastin showed a single band in SDS polyacrylamide gel electrophoresis, and the molecular weight was about 3.
It was 0000 Daltons. Furthermore, when the N-terminus was determined by Eman decomposition, Val - G) y - V
The sequence was confirmed to be al-Pro-Gay, and we were able to confirm that the target tropoelastin was produced by E. coli.
IIL二枯11菌−発現ベクター−αイ竹暫枯草菌α−
アミラーゼのプロモーターとシグナルペプチド遺伝子と
を持つpTUB228(K.Ohmura等、J. B
jochem. 95, 87. 1984)を用いて
枯草菌発現ベクターを作製した。IIL Bacillus subtilis 11 - Expression vector - α I Bacillus subtilis α -
pTUB228 (K. Ohmura et al., J.B.
jochem. 95, 87. A Bacillus subtilis expression vector was created using the following method (1984).
(1) pEL]2のCla1部位をIlindTIT
部位としたプラスミドpEI、12−1を用意し、エラ
スチンcDNAを含む約3kbのllindTII−旧
ndrllr)NA断片をpTUB22Bの旧nd11
1部位に挿入した。この結果、α−アミラーゼシグナル
ペプチドの下流に旧ndT11部位を介してエラスチン
cDNAが連結した枯草菌発現ベクターpEL112が
得られた。(1) IlindTIT the Cla1 site of pEL]2
Prepare the plasmid pEI, 12-1, and insert the approximately 3 kb llindTII-old ndrllr)NA fragment containing the elastin cDNA into the old nd11 of pTUB22B.
It was inserted into one site. As a result, a Bacillus subtilis expression vector pEL112 was obtained in which elastin cDNA was linked downstream of the α-amylase signal peptide via the old ndT11 site.
(2) pEL112をWilsonらの方法(Wi
Ison等、J。(2) pEL112 was purified using the method of Wilson et al. (Wi
Ison et al., J.
Bacteriol.95, 1439. 1968)
により、枯草菌(Bacillus subtilis
)Marburg168株に導入した。Bacteriol. 95, 1439. 1968)
Bacillus subtilis
) was introduced into Marburg168 strain.
このときの形質転換株の選択はカナマイシン耐性で行な
った。At this time, the transformed strain was selected based on kanamycin resistance.
(3)形質転換株をl、G培地で前記例2と同様に培養
した。培養後、例2と同様の方法により、培地から1・
「1ボエラスチンを単離した。(3) The transformed strain was cultured in L and G medium in the same manner as in Example 2 above. After culturing, 1.
``1 boelastin was isolated.
例−−−4一孔酵母−発−現ユ久り:ゴ生作製酵母、ガ
ラクトース1リン酸ウリジルトランスフェラーゼ遺伝子
G A L 7プロモーターを用いたプラスミド (■
)(特開昭60−248181号)を用いて酵母発現ベ
クターを作製した。Example --- 4 One hole yeast expression - Current status: Freshly produced yeast, plasmid using galactose monophosphate uridyl transferase gene GAL 7 promoter (■
) (Japanese Patent Application Laid-Open No. 60-248181) to create a yeast expression vector.
(1) plEL]2のC1arをプラントエンドにし
、NdeI消化したcDNAを含むDNA断片を、プラ
スミド(1)の13g1llをプラントエンドにしNd
eTで消化した2μoriを含むI”)NA断片に結合
した。この結果、GAI、7転写開始点下流20bpに
C1alリンカ−由来のATGが存在する酵母発現ベク
ターが得られた。(1) Change C1ar of plEL]2 to the plant end, and add the DNA fragment containing the NdeI-digested cDNA to the plant end, and convert 13g1ll of plasmid (1) to the plant end.
It was ligated to the eT-digested 2μori-containing I''NA fragment. As a result, a yeast expression vector was obtained in which an ATG derived from the C1al linker was present at 20 bp downstream of the GAI and 7 transcription start sites.
(2)得られた発現ベクターを塩化リチウム法(11,
Ito等、J、Bacteriol、153.163.
1983)により酵IU、(Saccharomyce
s cerevisiaelM ′FB −1株(M。(2) The obtained expression vector was expressed using the lithium chloride method (11,
Ito et al., J. Bacteriol, 153.163.
(1983) by yeast IU, (Saccharomyce
S cerevisiael M'FB-1 strain (M.
Tajima等、Mo1.Co11.8io1.6,2
46.1986)に導入した。このとき、形質転換株の
選択はウラシル非要求性を用いた。Tajima et al., Mo1. Co11.8io1.6,2
46.1986). At this time, uracil non-auxotrophy was used to select the transformed strain.
(3)形質転換株を最少培地(0,66%酵Lυし素源
ベース、0.5%カザミノ酸、0.002%I、−1〜
リプトファン、0.004%アデニン、2%ガラクトー
ス)500m+8で30℃で2日間振とう培養した。培
養後、集菌し、例2と同様の方法で細胞破壊後、トロポ
エラスチンを分離精製した。(3) The transformed strain was grown on minimal medium (0.66% fermentation Lυ source base, 0.5% casamino acids, 0.002% I, -1 to
Lyptophan, 0.004% adenine, 2% galactose) 500m+8 was cultured with shaking at 30°C for 2 days. After culturing, the cells were harvested, the cells were disrupted in the same manner as in Example 2, and tropoelastin was separated and purified.
例−y (1)以下の成分から本発明による化粧水を調製した。Example-y (1) A lotion according to the present invention was prepared from the following ingredients.
(重量%)
トロポエラスチン(二ワトつ由&) 0.5グリセ
リン 10ポリオキシエチレンイ
ソステアリルアルコール(POE 15モル)0.5
香料 適軍
精製水 残 余(製 法)
精製水にトロポエラスチン、グリセリン、ポリリオキシ
エチレンイソステアリルアルコールを添加し、室温にて
攪拌熔解した後、濾過した。(Weight %) Tropoelastin (Niwato Tsuyu &) 0.5 Glycerin 10 Polyoxyethylene isostearyl alcohol (POE 15 mol) 0.5
Fragrance Optimal Purified Water Residue (Production Method) Tropoelastin, glycerin, and polylioxyethylene isostearyl alcohol were added to purified water, stirred and dissolved at room temperature, and then filtered.
(2)肌荒れ改善効果
例5(1)で得た化粧水と、トロポエラスチンを配合し
ない(精製水で置換)で調製した対照用化粧水とについ
て、それらを用いて人体パネルで肌荒れ改善効果試験を
行った。(2) Skin roughness improvement effect example 5 The skin roughness improvement effect was measured using a human body panel using the lotion obtained in (1) and a control lotion prepared without tropoelastin (replaced with purified water). The test was conducted.
(試験方法)
女性健常人(顔面)の皮膚表面形態をシリコーン樹脂に
よってレプリカに取り、顕微鏡(17倍)にて観察する
。(Test method) A replica of the skin surface morphology of a healthy female person (face) is taken using silicone resin and observed under a microscope (17x magnification).
皮紋の状態及び角層の剥離状態から表−1に示す肌荒れ
評価1.2と判定された者(肌荒れパネル)24名を用
いて顔面左右半々に例5(1)の化粧水と対照用の化粧
水とを1日1回塗布した。Using the lotion of Example 5 (1) and the control lotion, applied to the left and right half of the face of 24 people (skin roughness panel) who were judged to have a skin roughness rating of 1.2 as shown in Table 1 based on the condition of skin marks and peeling of the stratum corneum. I applied this lotion once a day.
(評価方法)
1週間後、再度レプリカをとり、肌の状態を表−1の判
定基準に従って評価した。(Evaluation method) One week later, a replica was taken again and the condition of the skin was evaluated according to the criteria in Table 1.
結果を表−2に示す。The results are shown in Table-2.
表−1レプリカ法における判定基(18※ 肉眼的にも
スケールを認める
表−2化粧水を使用してから1週間後の肌質評価
表−2の結果より、トロポエラスチン配合の化粧水を使
用した顔面部位は対照用化粧水を使用した顔面部位と比
較して、顕著な肌荒れ改善効果が認められた。Table 1 Judgment criteria for the replica method (18* Scale is also visible to the naked eye) Table 2 Skin quality evaluation 1 week after using the lotion From the results of Table 2, it was determined that the lotion containing tropoelastin was The facial area where the lotion was used had a remarkable effect on improving rough skin compared to the facial area where the control lotion was used.
(3)日焼は後の皮膚改善効果
(試験方法)
東芝4O−3Eランプ(tJVB)6燈を用い、30c
n+の距離から男性パネル20名の前腕左右それぞれ3
c111角に8w4域紫外線を6分間照射し、人為的に
日焼けを起す。日焼けにより肌荒れが生じるので、照射
当日より前記例5(1)で得た化粧水と、トロポエラス
チンを配合していない対照用化粧水とを1日2回左右そ
れぞれに10日間塗布して、肌荒れ改善効果を調べた。(3) Skin improvement effect after sunburn (test method) Using Toshiba 4O-3E lamp (tJVB) 6 lights, 30c
3 on each side of the left and right forearms of 20 male panelists from a distance of n+.
The c111 corner is irradiated with 8W4 ultraviolet rays for 6 minutes to create an artificial sunburn. Since sunburn causes rough skin, from the day of irradiation, the lotion obtained in Example 5 (1) above and a control lotion containing no tropoelastin were applied twice a day to the left and right sides for 10 days. We investigated its effect on improving rough skin.
(評価方法)
日焼は後の肌荒れ改善状態を10日目にレプリカ法にて
観察、前記表−1の判定基準に従って評価した。(Evaluation method) The improvement of rough skin after sunburn was observed on the 10th day using the replica method, and evaluated according to the criteria shown in Table 1 above.
結果を表−3に示す。The results are shown in Table-3.
表−3化粧水を使用してから10日後の肌質評価
トロポエラスチン配合化粧水の使用により、日焼は後の
顕著な肌荒れ改善効果が認められた。Table 3 Evaluation of skin quality 10 days after using the lotion The use of the tropoelastin-containing lotion was found to have a significant effect on improving rough skin after sunburn.
例−」 以下の成分から本発明による化粧水を調製した。Example-” A lotion according to the present invention was prepared from the following ingredients.
(重量%)
トロポエラスチン(ビヴゾ*P%) 0.000
1グリセリン 3.0】、3−
ブチレングリコール 4,0エタノール
8.0ポリオキシエチレンオレイ
ルフル:J−B(POE 15モB)
0. 5メチルパラベン 0
.1クエン酸 O1旧ク
エン酸ソーダ O0■ヘチマ
抽出液 0・3香料
適量
精製水 残 余(製 法
)
精製水中にクエン酸、クエン酸ソーダ、グリセリン、ト
ロポエラスチン、1.3−ブチレングリコール、ヘチマ
抽出液を溶解する。別にエタノールにポリオキシュチレ
ンオレイルアルコール、香料、メチルパラベンを溶解し
、これを前述の精製水溶液に加えて可溶化しろ過して化
粧水を得た。(Weight%) Tropoelastin (Vivzo*P%) 0.000
1 glycerin 3.0], 3-
Butylene glycol 4,0 ethanol
8.0 Polyoxyethylene oleyl full: J-B (POE 15 MoB)
0. 5 Methylparaben 0
.. 1 Citric acid O1 Old sodium citric acid O0 ■ Loofah extract 0.3 Fragrance
Appropriate amount of purified water Remainder (manufacturing method) Dissolve citric acid, sodium citrate, glycerin, tropoelastin, 1,3-butylene glycol, and loofah extract in purified water. Separately, polyoxytylene oleyl alcohol, fragrance, and methylparaben were dissolved in ethanol, and this was added to the above-mentioned purified aqueous solution to solubilize and filter to obtain a lotion.
−側御υ 以下の成分からクリームを調製した。- side υ A cream was prepared from the following ingredients.
以下余白
(重量%)
(製 法)
A相を加熱溶解し75℃に保ったものを、75℃にて加
熱溶解したB相に攪拌しながら加える。Below is the margin (% by weight) (Manufacturing method) Phase A was dissolved by heating and kept at 75°C, and then added to Phase B, which was heated and dissolved at 75°C, with stirring.
ホモミキサー処理し乳化粒子を細かくした後、攪拌しな
がら急冷しクリームを得た。After processing with a homomixer to make emulsified particles fine, the mixture was rapidly cooled while stirring to obtain cream.
例−β− 以下の成分から乳液を調製した。Example −β− An emulsion was prepared from the following ingredients.
(重量%)
ステアリン酸 1.5セチル
アルコール 0.5イソプロピルミ
リステート 4.0スクワラン
5.0ミ′ンロウ
2.0ポリオキシエチレン(10モル)モ
ノオレイン 酸エステIt l、Qス
テアリン酸モノグリセリド 1.0り4y’P
r−V Jlllfl液 (5%水溶液)
20.0プロピレングリコール
5.0エチルアルコール 3.0香
料 適量
紫外線吸収剤 適 量精製水
残 余(製 法)
精製水にトロポエラスチンとプロピレングリコールとを
加え、加熱溶解して70°Cに保つ(水相)。(% by weight) Stearic acid 1.5 Cetyl alcohol 0.5 Isopropyl myristate 4.0 Squalane
5.0 min wax
2.0 Polyoxyethylene (10 mol) Monooleic acid ester It l, Q Stearic acid monoglyceride 1.0 4y'P
r-V Jllllfl liquid (5% aqueous solution)
20.0 Propylene glycol
5.0 Ethyl alcohol 3.0 Fragrance Appropriate amount Ultraviolet absorber Appropriate amount Purified water
Residue (manufacturing method) Add tropoelastin and propylene glycol to purified water, dissolve with heat, and keep at 70°C (aqueous phase).
エチルアルコールに香料、紫外線吸収剤を加えて溶解す
る(アルコール相)。残りの成分のうち、クインスシー
ド抽出液以外の成分を混合し、加熱溶解して70℃に保
つ(油相)。水相に油相を加え予備乳化を行い、ホモミ
キサーで均一に乳化する。これを撹拌しながらアルコー
ル相とクインスシード抽出液を加える。その後攪拌しな
がら30℃に冷却して乳液を得た。Add fragrance and UV absorber to ethyl alcohol and dissolve (alcohol phase). Among the remaining components, the components other than the quince seed extract are mixed, dissolved by heating, and kept at 70° C. (oil phase). Pre-emulsify by adding the oil phase to the water phase and homogeneously emulsify using a homomixer. While stirring, add the alcohol phase and quince seed extract. Thereafter, the mixture was cooled to 30° C. while stirring to obtain a milky lotion.
例−J− 以下の成分からパンクを調製した。Example-J- Punk was prepared from the following ingredients.
(重量%)
ポリ上ニルアルコ−1岬(ケン化度asχ:重合度20
0’0) 1 5. 0ポリエチレングリコール
3.0プロピレングリコール
7.0エタノール 10
.0メチルパラベン 0.1トロ
ポエラスチン(マウス−LU 5.0コンドロイ
チン硫酸ナトリウム 0.05香料
適量
精製水 残 余(製 法
)
精製水にポリエチレングリコール、プロピレングリコー
ル、メチルパラベン、トロポエラスチン、コンドロイチ
ン硫酸ナトリウムを加え攪拌溶解する。つぎにポリビニ
ルアルコールを加えて加熱溶解し、香料を溶解したエタ
ノールを加え攪拌溶解してバンクを得た。(Weight %) Polyester Nylalco-1 Misaki (Saponification degree asχ: Polymerization degree 20
0'0) 1 5. 0 polyethylene glycol
3.0 propylene glycol
7.0 ethanol 10
.. 0 Methylparaben 0.1 Tropoelastin (mouse-LU 5.0 Sodium chondroitin sulfate 0.05 Fragrance
Appropriate amount of purified water Remainder (manufacturing method) Add polyethylene glycol, propylene glycol, methylparaben, tropoelastin, and sodium chondroitin sulfate to purified water and dissolve with stirring. Next, polyvinyl alcohol was added and dissolved by heating, and ethanol in which the fragrance had been dissolved was added and dissolved with stirring to obtain a bank.
例−」−四
以下の成分からスカルブトリートメント(頭皮用化粧料
)を調製した。Example - A scalp treatment (scalp cosmetic) was prepared from four or less ingredients.
(重量%)
Δ
(製 法)
C相を75℃で溶解したものを、75℃に保ったB相に
攪拌しながら添加し、さらに、室温で充分攪拌溶解した
D相を添加し、攪拌しながら冷却し50℃で少量の精製
水に溶解した人相を添加し、さらに30℃まで攪拌冷却
してスカルブトリートメントを得た。(Weight %) Δ (Production method) Phase C dissolved at 75°C was added to Phase B maintained at 75°C with stirring, and then Phase D, which had been sufficiently stirred and dissolved at room temperature, was added and stirred. The mixture was cooled to 50°C, and a human phase dissolved in a small amount of purified water was added thereto, and the mixture was further stirred and cooled to 30°C to obtain a scalp treatment.
一例□□11− 以下の成分から吸水軟膏を調製した。Example □□11- A water-absorbing ointment was prepared from the following ingredients.
(重量%)
ワセリン 40.0ステア
リルアルコール 18.0モクロウ
20.0ポリオキシエチレン(1
0モル)モノオレイン 酸エステル 0
.25ステアリン酸モノグリセリド 0.25
トロポエラスチンにソトリ由t) 2.0精製
水 残 余(製 法)
精製水にトロポエラスチンを加え、70℃に保つ(水相
)。他の成分を70℃にて混合溶解する(油相)。油相
に水相を加え、ホモミキサーで均一に乳化後冷却して吸
水軟膏を得た。(Weight%) Vaseline 40.0 Stearyl Alcohol 18.0 Mokuro
20.0 polyoxyethylene (1
0 mol) Monooleic acid ester 0
.. 25 Stearic acid monoglyceride 0.25
2.0 Purified water (manufacturing method) Add tropoelastin to purified water and keep at 70°C (aqueous phase). Other components are mixed and dissolved at 70°C (oil phase). The aqueous phase was added to the oil phase, uniformly emulsified using a homomixer, and then cooled to obtain a water-absorbing ointment.
例6〜11の皮膚外用剤はそれぞれ皮膚および頭皮に使
用した時、全て皮膚改善効果に優れ、皮膚刺激性や感作
性が少なく、経時安定性にも優れ、好適に使用できるも
のであった。When used on the skin and scalp, the external skin preparations of Examples 6 to 11 all had excellent skin-improving effects, little skin irritation and sensitization, and excellent stability over time, so they could be used suitably. .
例−1−′L
以下の成分から常法により乳化ファンデーションを調製
した。Example-1-'L An emulsified foundation was prepared from the following ingredients in a conventional manner.
(重壁%)
ステアリン酸 1.2パルミ
チン酸 0.8セチルアルコー
ル 2.0流動パラフイン
12.0セチルイソオクタネート
5.0ジメチルポリシロキサン(6cs)
3.0デカメチルシクロペンタシロキサン 3
.0防腐剤 0.3酸化
防止剤 0.05香料
0.3
精製水 46.5プロピレ
ングリコール 5.0ポリエチレングリ
コール 5.0トロポエラスチンC=ソト
リ*氷) 0.5ヒアルロン酸ナトリウム
0.1水酸化カリウム
0.2二酸化チタン 6・
0赤色酸化鉄 0.32黄色
酸化鉄 0.75黒色酸化鉄
0.2タルク
5.0カオリン
2.73分散剤
0.05例−13−
以下の成分から常法により化粧下地を調製した。(Heavy wall%) Stearic acid 1.2 Palmitic acid 0.8 Cetyl alcohol 2.0 Liquid paraffin
12.0 Cetyl Isooctanate
5.0 dimethylpolysiloxane (6cs)
3.0Decamethylcyclopentasiloxane 3
.. 0 Preservatives 0.3 Antioxidants 0.05 Fragrances
0.3 Purified water 46.5 Propylene glycol 5.0 Polyethylene glycol 5.0 Tropoelastin C=Sotri*Ice) 0.5 Sodium hyaluronate
0.1 potassium hydroxide
0.2 Titanium dioxide 6.
0 Red iron oxide 0.32 Yellow iron oxide 0.75 Black iron oxide 0.2 Talc
5.0 kaolin
2.73 Dispersant
Example 0.05-13- A makeup base was prepared from the following ingredients in a conventional manner.
(重量%)
ステアリン酸 0.5イソステ
アリン酸 0.5スクワラン
8グリセリルトリイソオクタネー
ト 2ワセリン lセ
トステアリルアルコール 0.5POE付加
グリセリルモノステアレート 1.0ジグリセリルジイ
ソステアレート 1.0防゛腐剤
0.3酸化防止剤
0.05香料 0.3
精製水 68.151.3
−ブチレングリコール 10,0グリセリン
1.0トロポエラスチンにワ
トリ窃4) 0.5ポリアクリル酸
0.1水酸化カリウム
O0■エチルアルコール
5.0例 14
以下の成分から常法によりパウダリーフアンプ−ジョン
を調製した。(Weight%) Stearic acid 0.5 Isostearic acid 0.5 Squalane
8 Glyceryl triisooctanate 2 Vaseline l Cetostearyl alcohol 0.5 POE-added glyceryl monostearate 1.0 Diglyceryl diisostearate 1.0 Preservative
0.3 antioxidant
0.05 Fragrance 0.3 Purified water 68.151.3
-Butylene glycol 10.0 Glycerin 1.0 Tropoelastin and Watori 4) 0.5 Polyacrylic acid
0.1 potassium hydroxide
O0 ■ Ethyl alcohol
5.0 Example 14 A powder leaf amplifier was prepared from the following ingredients in a conventional manner.
(重量%)
マイカ 47.29タルク
20.0カオリン
5.〇二酸化チタン
10.0酸化鉄
5.0ソルビタンセスキオレート
1.5スクワラン 5.0
トリメ子ロー+Ltnバントリイソス5yレート
5.0防腐剤
0.7香料 0.5
トロポエラスチンCζ・ンシ゛’d) 0.
旧例−1−5−
以下の成分から常法によりマスカラを調製した。(Weight%) Mica 47.29 Talc 20.0 Kaolin
5. 〇Titanium dioxide
10.0 iron oxide
5.0 Sorbitan Sesquiolate
1.5 Squalane 5.0
Trimeko Low + Ltn Vantorisos 5y rate
5.0 preservative
0.7 Fragrance 0.5 Tropoelastin Cζ・N'd) 0.
Old Example-1-5- Mascara was prepared from the following ingredients in a conventional manner.
(重量%)
液状ポリブテン(平均分子量1000) I Oマ
イク11クリスタリンワックス 8ソルビタンモ
ノステアレート 1ポリ第4ソエチレン(l
i、0.20そル)ソルヒタンモノステ7レート
1積製氷 23.99
ト1:1ボエラスチン(シ殉4)0・01酸化鉄ブラン
ク 10ダイトゾール(注1)
20ニスダイン(注2) 2
0ナイロン繊維 6防腐剤
適 量香料
適量
(注1)大東化成KK製のポリアクリル酸エチルエマル
ジョンの商品名
(注2)積木化学KK製のポリ酢酸ビニルエマルジョン
の商品名
例−Ll
以下の成分から常法により透明口紅を調製した。(% by weight) Liquid polybutene (average molecular weight 1000) IO Mic 11 Crystalline wax 8 Sorbitan monostearate 1 Polyquaternary soethylene (l
i, 0.20 solu) Solhitan monoster 7 rate
1 pile of ice 23.99
1:1 Boelastin (Shimaru 4) 0.01 Iron oxide blank 10 Daitosol (Note 1)
20 Varnish Dyne (Note 2) 2
0 Nylon fiber 6 Preservative
Appropriate amount of fragrance
Appropriate amount (Note 1) Trade name of polyethyl acrylate emulsion manufactured by Daito Kasei KK (Note 2) Trade name of polyvinyl acetate emulsion manufactured by Blockchain Chemical KK Example-Ll A transparent lipstick was prepared from the following ingredients in a conventional manner.
(重量%)
精製水 89.999グリ
セリン 5トロポエラスチンに
フトリ舅釆) 0.001ポリビニルアルコ
ール 1モノヘンジリデン−D−ソルビ
ト−ル 2ジヘンジリデン−D−ソルビト−ル 2染
料 適量
防腐剤 適 量香料
適量
例」ユ
以下の成分から常法により乳化口紅を調製した。(% by weight) Purified water 89.999 Glycerin 5 Tropoelastin and filtrate) 0.001 Polyvinyl alcohol 1 Monohenzylidene-D-sorbitol 2 Dihenzylidene-D-sorbitol 2 Dye Appropriate amount Preservative Appropriate amount Fragrance
Example of Appropriate Amount An emulsified lipstick was prepared from the following ingredients in a conventional manner.
(重量%)
ヒマシ油 50イソステア
リン酸ジグリセライド 10キャンデリラロウ
8マイクロクリスタリンワツクス
10P、O,F、、 (20)P、O,P、 (20)
2テトラテシルオクタテシル丁−テ+1
4赤色202号
1酸化チタン 1赤
色酸化鉄 2.95精製氷
10ピロリドンカルボン酸
ソーダ 11.3−ブチレングリコール
1.995ヒアルロン酸
0.、O05トロポエラスチン(ヒト貰$、)
0.05−例」−亀
以下の成分から常法により乳化エナメルを調製した。(Weight%) Castor oil 50 Isostearic acid diglyceride 10 Candelilla wax
8 Microcrystalline wax
10P, O, F, (20) P, O, P, (20)
2 Tetra Tesyl Octate Sil D - Te + 1
4 Red No. 202
Titanium monoxide 1 Red iron oxide 2.95 Refined ice
10 Sodium pyrrolidone carboxylate 11.3-Butylene glycol
1.995 hyaluronic acid
0. , O05 tropoelastin (human $)
0.05-Example'' - An emulsified enamel was prepared from the following ingredients in a conventional manner.
(重量%)
5 %ヒト■キシブ■ピ;1メヂルセルロース/水10
プロピレングリコール 0.1トロポエ
ラスチンにソ)h17釆) 0.03ニトロセ
ルロ一ズA秒 12アルキッド樹脂(ハー
サティノク酸
グリシティールエーテル変()1) 6シ
ユウクロースヘンゾエート 6クエン酸アセチ
ルトリブチル 5カンフアー
1.5酢酸−n−ブチル
32.4酢酸エチル 10ト
ルエン 15赤色202号
0.2二酸化チタン
0.8ベントン3B、(注1)1
(注1 ) NL Chemica1社製の有機変性モ
ンモリロナイトクレーの商品名
仔1119
以下の成分から常法により水系エナメルを調製した。(Weight%) 5% human Xib Pi; 1 methyl cellulose/10 water
Propylene glycol 0.1 Tropoelastin (17) 0.03 Nitrocellulose (A) 12 Alkyd resin (hersatinocic acid glycityl ether modified (2) 1) 6 Sucrose henzoate 6 Acetyl tributyl citrate 5 Camphor
1.5-n-butyl acetate
32.4 Ethyl acetate 10 Toluene 15 Red No. 202
0.2 titanium dioxide
0.8 Bentone 3B, (Note 1) 1 (Note 1) Organically modified montmorillonite clay, trade name 1119, manufactured by NL Chemica 1. A water-based enamel was prepared from the following ingredients by a conventional method.
(重量%)
ポリビニl) 7 Itココ−LとヒFロキシエチjト
セ)1トス を保護7■イトとする酢酸ビニル 単独ポ
リマーl711ジヨン (有効分50%)
8スチレン・メチルメック1ル
ート・フチルアクリレート2エチルへキシル7り1ルー
ト・メタクリル酸(千ツマー比19:60:10:6:
5重量比)よりなる共重合物のマイクロエマ1トシヨン
(有効分40%)60精製氷
16.99710ボエラスチン(ブタ由来)
0.003ポリオキンエチレンソルビタンモノオ
レエート 1ラポナイ
トX1.G 1イソプロピ
ルアルコール 5シエチレンクリフー;t
モノエチBI−チル
5顔料(赤色202号、黄色酸化鉄、
酸化チタン; 4:2:1)
2雲母チタン 1消泡剤
適 量防腐剤
適 量f′L−LO−
以下の成分からヘアブローローションを調製した。(% by weight) Polyvinyl acetate monopolymer (711%) (effective content 50%)
8 Styrene, Methyl MEC 1 root, Phthyl acrylate 2 Ethylhexyl 7 Root, Methacrylic acid (1,000 zum ratio 19:60:10:6:
Microemma copolymer (effective content: 40%) 60% purified ice
16.99710 Boelastin (pig origin)
0.003 Polyquine ethylene sorbitan monooleate 1 Laponite X1. G 1 isopropyl alcohol 5 ethylene chloride; t
Monoethi BI-chill
5 pigments (red No. 202, yellow iron oxide, titanium oxide; 4:2:1)
2 Mica titanium 1 Antifoaming agent
Appropriate amount of preservative
Appropriate amount f'L-LO- A hair blow lotion was prepared from the following ingredients.
(重量%)
(1)ジメチルポリシロキサン(5cs) 5(
2)流動パラフィン 3(3)ジプロ
ピレングリコール 5(4) ポリオキシエチ
レングリコール(60)硬化ヒマシ ?山2(5)トロ
ポエラスチンにワトリψ末) 0.5(6)エタノ
ール(95%)30
(7)香料 適量
(8) tm化システ7リルシメチルアンモニウムク
■ライト 0.3(9)イオン交換水
54.2成分(3) (4)を溶解した
ものに、成分(IO2)を添加して乳化した。成分(5
)〜(9)を溶解・混合し、上記該乳化物を添加した。(Weight%) (1) Dimethylpolysiloxane (5cs) 5(
2) Liquid paraffin 3 (3) Dipropylene glycol 5 (4) Polyoxyethylene glycol (60) Hardened castor? Mountain 2 (5) Tropoelastin and Watori ψ powder) 0.5 (6) Ethanol (95%) 30 (7) Fragrance Appropriate amount (8) TM Cyste 7lylsimethylammonium light 0.3 (9) ion exchange water
54.2 Component (3) Component (IO2) was added to the solution of (4) and emulsified. Ingredients (5
) to (9) were dissolved and mixed, and the above emulsion was added.
一側御−壮 以下の成分からヘアムースを調製した。One side go-so A hair mousse was prepared from the following ingredients.
(重壁%)
(1) 塩化システア1月1ンメチ:トアンモニウムク
lライ1 0.5(2)ジプロピレングリコ
ール 5(3) ポリオキシエチレン(40)
ジメチルポリシロキサン 3(4)ヤ
シ油アマイ1゛1
(5) ポリオキシエチレン(80) 硬化ヒマシ
ン由1(6)酸性アクリル酸ポリマー 3(商
品名プラスサイズL−53)
(7) l−n +f ニー7 スチ7 (:!−ソ
)lli末) 2(8)香料 適量
(9)ペプタイド加水分解物(MW700) 1
(10)イオン交換水 83.5成分
(1)〜(10)を溶解・混合し、原液とした。(Heavy-walled %) (1) Cystea chloride 1/1 mth: Toammonium chloride 1 0.5 (2) Dipropylene glycol 5 (3) Polyoxyethylene (40)
Dimethylpolysiloxane 3 (4) Coconut oil 1'1 (5) Polyoxyethylene (80) Hardened castor
1 (6) Acidic acrylic acid polymer 3 (Product name Plus Size L-53) (7) l-n +f Knee 7 Suti 7 (:!-So)lli powder) 2 (8) Fragrance Appropriate amount (9) Peptide Hydrolyzate (MW700) 1
(10) Ion exchange water 83.5 components (1) to (10) were dissolved and mixed to prepare a stock solution.
原液96重V部に対し噴射ガス(+、PG、25℃、圧
力4.0 kg> 4重量部を加えてエアゾール缶中に
充填した。To 96 parts by weight of the stock solution, 4 parts by weight of propellant gas (+, PG, 25°C, pressure 4.0 kg>4) was added and filled into an aerosol can.
例−2−2− 以下の成分から常法によりヘアリキッドを調製した。Example-2-2- A hair liquid was prepared from the following ingredients in a conventional manner.
(重量%)
(1) ポリオキシブlピレン(40)ブチ)【エーテ
1[10(2) ポリオキシブ11ピレン(70)デカ
グリセ1月【エーテル 10(3)トロポエラ
スチンにトI麺末) 5(4)香料 適
量
(5)パントテン酸エチルエーテル 0.5(6)
エタノール(95%)50
(7)イオン交換水 24.5成分(
1)〜(7)を溶解・混合した。(Weight %) (1) Polyoxybutyrene (40) buty) [ether 1 [10(2) polyoxybutylene 11pyrene (70) Decagrise Jan [ether 10(3) tropoelastin to I noodle powder] 5 (4 ) Fragrance appropriate amount (5) Pantothenic acid ethyl ether 0.5 (6)
Ethanol (95%) 50 (7) Ion exchange water 24.5 ingredients (
1) to (7) were dissolved and mixed.
例−は 以下の成分から常法によりヘアスプレーを調製した。Example - is A hairspray was prepared from the following ingredients in a conventional manner.
(重V%)
(1) 7りIJIL酸及びメタクリル酸とそれらのア
ルキルエステルとの共重合物t 5(2) メチIL
フェニI目すシロキサン20cs
1(3) POE(4)オレイルエーテル
0,5(4)エチルアルコール(99%)
76.5(5)トロポエラスチンにワYす*幻
7成分(1)〜(5)を攪拌溶解して原液とした。原液
50重量部に対して噴射ガス(フロン11/12=40
/60150重量部を加えてエアゾール缶中に充填して
ヘアスプレーを得た。(weight V%) (1) Copolymer of 7-IJIL acid and methacrylic acid and their alkyl esters 5(2) Meth-IL
Phenyl Messiloxane 20cs
1 (3) POE (4) Oleyl ether 0,5 (4) Ethyl alcohol (99%)
76.5(5) Tropoelastin was dissolved with stirring to obtain a stock solution. Injection gas (Freon 11/12 = 40 parts by weight for 50 parts by weight of stock solution)
A hair spray was obtained by adding 150 parts by weight of /60 and filling it into an aerosol can.
仔ヒ]」− 以下の成分からヘアトニックを調製した。子hi】”− A hair tonic was prepared from the following ingredients.
(重量%)
(1)プロピレングリコール 3.0(2)
パントテニールエチルエーテル 1.0(3)塩酸ジ
フェンヒドラミン 0.1(4)サリチル酸
0.1(5)トロポエラスチン(
:!−舛す古来)0.5(6) 7!−メントール
0.1(7)香料
0・5
(8)エタノール 40・0(9)
精製水 残 余(製 法)
成分(9)に、成分(1) (2) (3) (4)
(5)を攪拌混合した(A部)。他の成分を攪拌混合し
た(B部)。(Weight%) (1) Propylene glycol 3.0 (2)
Pantothenyl ethyl ether 1.0(3) Diphenhydramine hydrochloride 0.1(4) Salicylic acid
0.1 (5) Tropoelastin (
:! - Ancient times) 0.5 (6) 7! −Menthol
0.1 (7) Fragrance
0.5 (8) Ethanol 40.0 (9)
Purified water remainder (manufacturing method) Component (9), component (1) (2) (3) (4)
(5) was stirred and mixed (Part A). Other ingredients were stirred and mixed (Part B).
A部にB部を添加し攪拌混合して液状のヘアトニックを
得た。Part B was added to Part A and mixed with stirring to obtain a liquid hair tonic.
例−′L5− 以下の成分からスカルプトリートメントを調製した。Example-'L5- A scalp treatment was prepared from the following ingredients.
(重量%)
(1)流動パラフィン 15・0(2)
ワセリン 2.0(3)セタノ
ール 2.0(4)ポリエチレン
グリコール1500 7.0(5)ステアリン酸
2.5(6) POE(6)ソ1
1ヒタンモノステアレート
1.0(7)グリセリルモノステアレート1.0(8
)カセイカリ 1.0(9)トロ
ポエラスチン(を)す*1)3.0(10)キノリンエ
ロー 適 量(11)エチルパラベン
0.1(12)香 料
0,5(13)精製水
残 余(製 法)
成分(13)に成分(4) (8) (9) (10)
を加熱溶解し70℃に保った(A部)。他の成分を混合
し、加熱熔解して70℃に保った(B部)。A部にB部
を添加し攪拌混合した後、ホモミキサーにて乳化した。(Weight%) (1) Liquid paraffin 15.0 (2)
Vaseline 2.0 (3) Setanol 2.0 (4) Polyethylene glycol 1500 7.0 (5) Stearic acid
2.5 (6) POE (6) So1
1 Hitane Monostearate
1.0(7) Glyceryl monostearate 1.0(8
) Caustic potash 1.0 (9) Tropoelastin *1) 3.0 (10) Quinoline Yellow Appropriate amount (11) Ethylparaben 0.1 (12) Fragrance
0,5(13) Purified water
Residue (manufacturing method) Ingredient (13) and Ingredient (4) (8) (9) (10)
was heated and dissolved and kept at 70°C (Part A). Other ingredients were mixed, heated and melted and kept at 70°C (Part B). Part B was added to Part A, mixed with stirring, and then emulsified using a homomixer.
乳化後かきまぜながら30℃まで冷却して乳液状のスカ
ルプトリートメントを得た。After emulsifying, the mixture was cooled to 30° C. while stirring to obtain a milky scalp treatment.
例−ユ−W 以下の成分からプレシャンプー剤を調製した。Example-Yu-W A pre-shampoo preparation was prepared from the following ingredients.
(重量%)
(1)ポリビニールアルコール 2.0(2)
クエン# 0.5(3)
lりオキシエチレン(10)オレイルエーテル
1.0(4)ジプロピレングリコー
ル 10.0(5)ヒドロキシエチルセルロース
0.5(6)キサンタンガム
0.5(7)香料 0.5
(8)精製水 残 余(9)
トロポエラスチンにワトリ窃i) 1.0(製 法
)
成分(4)に、成分(5) (6)を湿潤分散させた(
A部)。他の成分を混合し、加熱溶解した後常温(室温
)まで冷却した(B部)。B部にA部を添加し攪拌混合
し、粘液状のプレシャンプー剤を得た。(Weight%) (1) Polyvinyl alcohol 2.0 (2)
Quen # 0.5 (3)
oxyethylene (10) oleyl ether
1.0 (4) Dipropylene glycol 10.0 (5) Hydroxyethyl cellulose 0.5 (6) Xanthan gum
0.5 (7) Fragrance 0.5 (8) Purified water Remaining (9)
1.0 (Production method) Components (5) and (6) were wet-dispersed in tropoelastin (1.0 (manufacturing method)).
Part A). Other components were mixed, heated and dissolved, and then cooled to normal temperature (room temperature) (Part B). Part A was added to Part B and mixed with stirring to obtain a slimy pre-shampoo.
一例−」し1 以下の成分から常法により毛髪着色料を調製した。An example - 1 A hair colorant was prepared from the following ingredients in a conventional manner.
以下余白
(重量%)
〔苛性ソーダ(10%水溶液)1.0
相
(製 法)
A相にB相とC相とD相を順次添加し、撹拌混合して調
製した。The following margin (% by weight) [Caustic soda (10% aqueous solution) 1.0 Phase (manufacturing method) Phase B, C, and D were sequentially added to phase A and mixed by stirring.
例 28 以下の成分から常法番こより染毛料を調製した。Example 28 A conventional hair dye was prepared from the following ingredients.
以下余白
、 (74)
(重量%)
B
〔ヒドロキシエチルセルロース 0.5部
〔クエン酸 1.5部
(製 法)
A部にB部を徐々に撹拌しながら加えて粘稠液を調製し
た。この粘稠液に0部の各色素を溶解させ、D部でpH
を3.2〜3.5に調整し、赤褐色用染毛料を得た。The following is a margin: (74) (% by weight) B [Hydroxyethyl cellulose 0.5 parts [Citric acid 1.5 parts (manufacturing method) Part B was gradually added to Part A with stirring to prepare a viscous liquid. Dissolve 0 parts of each dye in this viscous liquid, and adjust the pH in part D.
was adjusted to 3.2 to 3.5 to obtain a reddish brown hair dye.
例 29
以下の成分から常法により水溶性ゲル状整髪料を調製し
た。Example 29 A water-soluble gel hair conditioner was prepared from the following ingredients in a conventional manner.
(重壁%)
合計 100.0
(製 法)
A相とB相を70〜90℃で撹拌溶解後、両者を混合し
て0℃の一定温度にて冷却して得た。(% of heavy walls) Total 100.0 (Production method) Phase A and phase B were stirred and dissolved at 70 to 90°C, then mixed and cooled at a constant temperature of 0°C.
秒1」」− 以下の成分から常法により酸化染毛剤を調製した。Second 1””- An oxidative hair dye was prepared from the following ingredients in a conventional manner.
(重量%)
第 1 ′N1し ポリオキシエチレン(2)オレイル
エーテル 14オレイン酸
12
プロピレングリコール 10
エタノール 8
パラフエニレンジアミン ル
ゾルシン 0.5
メタアミノフエノール 0.2エデト酸ナトリ
ウム 0.1チオグリコール酸
0.1トロポエラスチン(二vMd> 1.。(% by weight) 1st 'N1 Polyoxyethylene (2) Oleyl ether 14 Oleic acid
12 Propylene glycol 10 Ethanol 8 Paraphenylenediamine Lusorcin 0.5 Metaaminophenol 0.2 Sodium edetate 0.1 Thioglycolic acid
0.1 tropoelastin (2 vMd > 1.
アンモニア水 pHloに調整香料
0.1
精製水 全体を100χにする量精製水に順
次他の成分を加え撹拌溶解して第1剤を得た。Ammonia water Adjusted to pHlo Fragrance
0.1 Purified water Other ingredients were sequentially added to the purified water in an amount to make the whole 100χ and dissolved with stirring to obtain the first agent.
第2剤:過酸化水素水(30%)20
リン酸バツフアー pH4に調整精製水
全体を100χにする量精製水に順次他の成分を
加え攪拌溶解し、第2剤を得た。Part 2: Hydrogen peroxide (30%) 20% Phosphate buffer Adjusted to pH 4 Purified water
Other ingredients were sequentially added to the purified water in amounts to make the whole 100χ and dissolved with stirring to obtain a second agent.
、例 31 以下の成分から常法により染毛剤を調製した。, Example 31 A hair dye was prepared from the following ingredients in a conventional manner.
(重量%)
第 1 斉し ポリオキシエチレン(5)ノニ11フェ
ニルエーテIL15オレイン酸 1
0
プロピレングリコール 10
エタノール 8
パラフエニレンジアミン ル
ゾルシン 0.3
エデト酸ナトリウム O3l千オグリコール
酸 0.1アンモニア水
p旧0調整香料 0.1
精製水 100部調整第2剤:過酸
化水素水(30%)20
トロポエラスチンCv−レr’f、> 0.5リ
ン酸バツフアー pH4調整精製水
100部調整例30および31の第1剤と
第2剤をそれぞれ等積混合し、白髪毛髪に塗布し、約2
0分間放置後に、洗い流したところ、毛髪は十分に染色
され、使用中および使用後の頭皮への刺激も認められな
かった。(% by weight) 1st polyoxyethylene (5) noni 11 phenyl ether IL 15 oleic acid 1
0 Propylene glycol 10 Ethanol 8 Paraphenylenediamine Lusorcin 0.3 Sodium edetate O31000-glycolic acid 0.1 Aqueous ammonia
p Old 0 adjusted fragrance 0.1 Purified water 100 parts Adjusted 2nd agent: Hydrogen peroxide solution (30%) 20 Tropoelastin Cv-R'f, > 0.5 Phosphate buffer pH 4 adjusted purified water
100 parts The first and second parts of Preparation Examples 30 and 31 were mixed in equal volumes, applied to gray hair, and applied to gray hair.
When the hair was left to stand for 0 minutes and then washed off, the hair was sufficiently dyed and no irritation to the scalp was observed during or after use.
例−32 1ソ下の成分からむだ毛脱色剤を調整した。Example-32 An unwanted hair bleaching agent was prepared from ingredients below 1 so.
〔1剤〕 (重量%)(ア
ンモニア水試薬特級(28%)5.0相
A相を加熱溶解して70℃に保ったものを、70℃にて
加熱溶解したB相に攪拌しながら加える。ホモミキサー
処理し、乳化粒子を細かくした後、撹拌しながら急冷し
てクリームを得る。さらに、これにC相を加え撹拌し均
一な1剤クリームを得た。[1 agent] (wt%) (Ammonia water reagent special grade (28%) 5.0 phase Dissolve phase A by heating and keep it at 70°C, and add it to phase B, which was dissolved by heating at 70°C, with stirring. After processing with a homomixer to make the emulsified particles fine, the mixture was rapidly cooled while stirring to obtain a cream.Furthermore, phase C was added thereto and stirred to obtain a uniform one-drug cream.
〔2剤〕 (重量%)A相
を加熱溶解し、70℃に保ったものを、70℃にて加熱
溶解したB相に撹拌しながら加える。ホモミキサー処理
し、乳化粒子を細かくした後、撹拌しながら急冷して2
剤クリームを得た。[Part 2] (% by weight) Phase A was dissolved by heating and kept at 70°C, and then added to Phase B, which had been heated and dissolved at 70°C, with stirring. After processing with a homomixer to make the emulsified particles fine, the mixture is rapidly cooled while stirring.
A cream was obtained.
本実施例32の1剤と2剤を等量混合し、手および足の
むだ毛のある部分に塗布し、約15分後に洗い流したと
ころ、むだ毛は均一に脱色され、使用後の肌荒れもなく
、望ましいものであった。When I mixed equal amounts of agents 1 and 2 of this Example 32, applied it to areas with unwanted hair on my hands and feet, and washed it off after about 15 minutes, the unwanted hair was evenly bleached and my skin did not get rough after use. However, it was desirable.
また使用中の刺激も全く認められなかった。Further, no irritation was observed during use.
(重量%)
(1)トロポエラスチン(シフト9*$) 7(
2) 1 、3−ブチレングリコール 5(3)
未変性エタノール 5(4)メチルパラ
ヘン 0.3(5)プロピルパラベン
0.03(6)香料 適量
(7)イオン交換水 全体を100χとする量(
製 法)
成分(1)を成分(7)に溶解する。これに、成分(2
)〜(6)を混合溶解したものを加え、撹拌混合して調
製した。(Weight%) (1) Tropoelastin (shift 9 * $) 7 (
2) 1,3-butylene glycol 5(3)
Undenatured ethanol 5 (4) Methylparahen 0.3 (5) Propyl paraben 0.03 (6) Fragrance Appropriate amount (7) Ion exchange water Amount to make the whole 100χ (
Manufacturing method) Dissolve component (1) in component (7). Add to this the ingredient (2
) to (6) were mixed and dissolved, and the mixture was stirred and mixed.
一例 34 以下の成分からヘアトリートメントを調製した。Example 34 A hair treatment was prepared from the following ingredients.
(重量%)
(1)入テア1ハシアルコール のエチレンオキシド打
力n物o、5(2)ステアリルアルコール
2.0(3) 塩化ステア1ハlトリメチルアンモニウ
ム (27%)1.4(4) 4化シアγす1岬ジメ
チル7ン干ニウム(73%)0.8(5)プロピレング
リコール 3.0(6)トロポエラスチン(
二V)Q*1 1.5(7)香料 適量
(8)イオン交換水 全体を100χとする量(
製 法)
成分(1)〜(4)を秤取し、80℃位に加湿溶解させ
た(A相)。A相を、80℃位の成分(8)に加え撹拌
混合した(B相)。B相に、順次成分(5) (6)
(7)を添加し、攪拌混合した(C相)。C相を冷却(
30℃)した。(Weight %) (1) Ethylene oxide impact strength of tare alcohol, 5 (2) Stearyl alcohol
2.0 (3) Stear trimethylammonium chloride (27%) 1.4 (4) Stear 1 halide trimethyl ammonium chloride (73%) 0.8 (5) Propylene glycol 3.0 (6) Tropoelastin (
2V) Q*1 1.5 (7) Fragrance Appropriate amount (8) Ion exchange water Amount to make the whole 100χ (
Manufacturing method) Components (1) to (4) were weighed out and dissolved in a humidified manner at about 80°C (A phase). Phase A was added to component (8) at about 80°C and mixed with stirring (Phase B). In phase B, sequential components (5) (6)
(7) was added and mixed with stirring (phase C). Cool phase C (
30°C).
秒l 以下の成分からヘアコンディショナーを調製した。seconds l A hair conditioner was prepared from the following ingredients.
(重量%)
(1)トロポエラスチンにワYv責1) 0.8
(2)4化ステアリルトリメチルアンモニウム (60
%)2.0(3)流動パラフィン 1
.4(4) 1りオキシエチレンセチルI−テ11
(20千B) 1.2(5)セタ
ノール 2.4(6)香料
適量
(7)クエン酸 適 量(8)イ
オン交換水 全体を100χとする量(製 法)
成分(3) (4) (5)を秤取し、80℃位まで加
熱して溶解した(A相)。80℃の成分(8)に、A相
を添加し、撹拌混合した(B相)。B相に、成分(7)
(6)を順次加え、攪拌混合した(C相)。C相を、
40℃位で撹拌冷却した。(Weight%) (1) Contribution to tropoelastin 1) 0.8
(2) Stearyltrimethylammonium tetrachloride (60
%) 2.0 (3) Liquid paraffin 1
.. 4(4) 1-oxyethylenecetyl I-te11
(20,000B) 1.2 (5) Cetanol 2.4 (6) Fragrance
Appropriate amount (7) Citric acid Appropriate amount (8) Ion-exchanged water Amount to make the whole 100χ (manufacturing method) Components (3), (4), and (5) were weighed out and dissolved by heating to about 80°C (A phase). Phase A was added to component (8) at 80° C. and mixed with stirring (phase B). In phase B, component (7)
(6) were added one after another and mixed with stirring (phase C). C phase,
The mixture was stirred and cooled to about 40°C.
例 36 以下の成分から常法によりヘアクリ−J、を調製した。Example 36 Hair cream J was prepared from the following ingredients in a conventional manner.
(重量%)
(1)トロポエラスチ刈シぐトリ會、i) 0.
4(2)ステアリン酸 13.0(3
)セタノール 2.0(4) エ
デレングリゴールシステ7レート
4.0(5)シリコーンオイルKF9t
、、3夕D(J O,2(6)トリエタノールアミ
ン 1.6(7)プロピレングリコール
8.0(8)エデト酸塩
0.1(9)香料 適量
(10)イオン交換水 全体を1007とする量
(製 法)
成分(2)〜(5)を秤量し、約80℃に加温溶解した
(A相)。成分(6) (7) (8) (10)を第
1す、約80℃に加ン誓、シた後、成分(1)を加えた
(B相)。(Weight %) (1) Tropoelasti shearing bird association, i) 0.
4(2) Stearic acid 13.0(3
) Setanol 2.0 (4) Edelengrigol cyste 7 rate
4.0 (5) Silicone oil KF9t
,,3 D(J O,2(6) Triethanolamine 1.6(7) Propylene glycol
8.0(8) Edetate
0.1 (9) Perfume Appropriate amount (10) Ion-exchanged water Amount to make the total 1007 (Production method) Components (2) to (5) were weighed and dissolved by heating at about 80°C (Phase A). Ingredients (6), (7), (8), and (10) were heated to about 80° C., and then component (1) was added (phase B).
B相にA相を徐々に加えて攪拌し、約60℃で成分(9
)を加え、約4!O℃で攪拌をとめて調製した。Gradually add phase A to phase B, stir, and mix the ingredients (9) at about 60°C.
), about 4! The mixture was prepared by stopping stirring at 0°C.
−例」7− 以下の成分からパーマネント・ウェーブ剤を調製した。-Example 7- A permanent waving agent was prepared from the following ingredients.
第1剤; (重量%)子オ
グリコール酸7シモニウム
12.5(チオグリコール酸として50%)
アンモニア水試薬特級(28%)1.5炭酸水素アンモ
ニウム 3.5トロポエラスチン(:l
−ワトを神!t 0.5塩化ステア1ハレトリ
メチル7ンモニウム (80%)0.1ポリオキシエチ
レン(20モルイ寸加(本)オレイルl−テ+L
O,5香料 0.1
精製水 81.3ポリオキ
シエチレン(20モル)オレイルエーテルを加熱融解さ
せ、香料を加えて攪拌した後、これを精製水に加えて攪
拌溶解させた。次に、順次他の成分を加えて撹拌溶解し
、透明な本第1剤を得た。First agent; (wt%) 7-simonium oglycolic acid
12.5 (50% as thioglycolic acid) Ammonia water reagent special grade (28%) 1.5 Ammonium bicarbonate 3.5 Tropoelastin (:l
-Wato is God! t 0.5 stear chloride 1 haletrimethyl 7 ammonium (80%) 0.1 polyoxyethylene (20 moles (unit) oleyl l-te + L
O,5 Perfume 0.1 Purified Water 81.3 Polyoxyethylene (20 mol) Oleyl ether was heated and melted, perfume was added and stirred, and then added to purified water and stirred and dissolved. Next, the other components were sequentially added and dissolved with stirring to obtain a transparent first agent.
第2剤; (重量%)臭素酸
ナトリウム 5.0第2リン酸ナト
リウム 0.1第1リン酸カリウム
0.3精製水
94.6精製水に順次他の成分を加えて攪拌溶解さ
せ、透明な本第2剤を得た。Second agent; (wt%) Sodium bromate 5.0 Sodium phosphate dibasic 0.1 Potassium monophosphate
0.3 Purified water
94.6 Other ingredients were sequentially added to the purified water and dissolved with stirring to obtain a transparent second agent.
人の頭髪に本第1剤80rrlを用いて、ロンドでワイ
ンデング・塗布してからキャップをかぶせ10分間放置
した。キャップを外し、中間水洗を行って余分な水分を
タオルで払き取った後、本第2剤100m1を2度に分
けて塗布し、15分間放置した。次にロンドを外し、水
洗後にタオルドライすると、しっとりとし、しなやかで
弾力のあるウェーブが得られた。ドライヤーで乾燥させ
るとつややかではりのあるウェーブに仕上げられた。80 rrl of the first agent was applied to human hair by winding and applying with a rond, and the hair was covered with a cap and left for 10 minutes. After removing the cap, performing an intermediate wash with water and wiping off excess water with a towel, 100 ml of the second agent was applied in two portions and left for 15 minutes. Next, I removed the ronde, washed it with water, and then towel-dried it, resulting in moist, supple, and bouncy waves. Drying it with a hairdryer gives it a shiny, wavy finish.
−例−3」− 以下の成分からパーマネントウェーブ剤を調製した。-Example-3''- A permanent waving agent was prepared from the following ingredients.
第1剤; (重量%)チオ
クリ7−ル 9yンモニウム
13.0(チオクリ7−ル酸として50
%)
ジチオジグリコール 酸ジアンモニウム
10.0(シチオシグリコ−1を酸
と して40%)アンモニア水試薬特級(28%)1.
0モノエタノールアミン 1.0炭酸
水素アンモニウム 2.5トロポエラス
チン(り會1> 1.0塩化ステ7リルトリ
メチ+17ンモニウム
0.5ポリオキシエチレン(15モル付方力イ本)
オレイルI−テit 0.5香料
0.2
エデト酸・4ナトリウム 0.1精製水
70.2ポリオキシエチレ
ン(15モル)オレイルエーテルを加熱融解させ、香料
を加えて攪拌した後、これを精製水に加え撹拌溶解させ
た。次に、順次他の成分を加えて攪拌溶解し、透明な本
第1剤を得た。First agent; (wt%) Thiocryl 7-9ymonium
13.0 (50 as thiocrylic acid)
%) Diammonium dithiodiglycolic acid
10.0 (40% using cythiosyglyco-1 as acid) Ammonia water reagent special grade (28%) 1.
0 Monoethanolamine 1.0 Ammonium bicarbonate 2.5 Tropoelastin (Relationship 1> 1.0 St7lyltrimethychloride + 17 ammonium
0.5 polyoxyethylene (15 molar force)
Oleyl I-tit 0.5 fragrance
0.2 Edetate tetrasodium 0.1 Purified water
70.2 Polyoxyethylene (15 mol) Oleyl ether was heated and melted, a fragrance was added and stirred, and then added to purified water and dissolved with stirring. Next, the other ingredients were sequentially added and dissolved with stirring to obtain a transparent first agent.
第2剤;
例37と同−
例37と同一の方法により、ウェットな時はしっとりと
し、しなやかで均一であり、弾力の有るウェーブが得ら
れた。ドライヤーで乾燥さ−Vるとつややかでかなりは
りのあるウェーブに仕上げられた。2nd Agent: Same as Example 37 - By the same method as Example 37, waves were obtained that were moist, supple, uniform, and elastic when wet. When I dried it with a hairdryer, I was able to get shiny and very firm waves.
秒トー↓」− 以下の成分からパーマネントウェーブ剤を調製した。Seconds ↓”− A permanent waving agent was prepared from the following ingredients.
第1剤; (重量%)チオグリコ
−+> 9アンモニウム
2.0(チオグリコール酸として50%
)
■、−システィン 6.5モノエ
タノールアミン 2.0アンモニア水
試薬特級(28%)1.5セタノール
0.3ラウリル硫酸ナトリウム
0.1ポリオキソエデレン(15モILイ寸力■体)
七デ1ジエーテル 0.1トロポエラス
チン(乙ヅy會Q> 0.7香料
0.08
エデト酸・4ナトリウム 0.2精製氷
86.52精製氷30%を
約80℃まで加熱し、これにセタノール、ラウリル硫酸
ナトリウムおよびポリオキシエチレン(15モル付加体
)セチルエーテルを加えて攪拌溶解させ、攪拌しながら
徐冷させて粘性液杖のゲルを生成させた。残りの精製水
(56,52%)に他の成分を配合して攪拌溶解させ、
先に調製したゲルと一緒にして撹拌して、粘性を持った
本第1剤を得た。First agent; (wt%) thioglyco-+>9 ammonium
2.0 (50% as thioglycolic acid)
) ■, -cysteine 6.5 Monoethanolamine 2.0 Ammonia water reagent special grade (28%) 1.5 Cetanol
0.3 Sodium lauryl sulfate
0.1 polyoxoederene (15mol IL)
Seven de-1 diether 0.1 Tropoelastin (Otsuzuyai Q> 0.7 Fragrance
0.08 Edetate tetrasodium 0.2 Purified ice
86.52 Heat 30% purified ice to about 80°C, add cetanol, sodium lauryl sulfate, and polyoxyethylene (15 mole adduct) cetyl ether, stir and dissolve, and slowly cool while stirring to form a viscous liquid. Created a cane gel. Add other ingredients to the remaining purified water (56.52%) and stir to dissolve.
This was stirred together with the previously prepared gel to obtain a viscous first agent.
第2剤;例37と同一
人の頭髪に本第1剤を80mAを用いて、ロンドでワイ
ンディング・塗布してからキャンプをかぶせ20分間放
置した。キャンプを外して中間水洗を行い、余分な水分
をタオルで払き取った後、本第2剤100rrlを2度
に分けて塗布し、15分間放置した。次に、ロンドを外
し、水洗後にタオルドライすると、つるつるとした滑ら
かな弾力の有るウェーブが得られた。ドライヤーで乾燥
させるとつややかではりのある均一なウェーブが得られ
、<Li[!lりも非常に良好であった。2nd agent: This 1st agent was applied to the hair of the same person as in Example 37 by winding with a ronde using 80 mA, and then covered with camp and left for 20 minutes. After removing the camp and performing an intermediate wash with water and wiping off excess water with a towel, 100 rrl of the second agent was applied in two doses and left for 15 minutes. Next, I removed the ronde, washed it with water, and then towel-dried it, resulting in smooth, bouncy waves. Drying with a hair dryer will give you shiny, firm, uniform waves, and <Li[! The resistance was also very good.
イタリー4ユ(1− 以下の成分からパーマネントウェーブ剤を調製した。Italy 4 units (1- A permanent waving agent was prepared from the following ingredients.
第1剤; (重量%)チオグリコ
ール 酸アンモニウム
12.0(チオクリコール酸と して50%)
アンモニア水試薬特級(28%)、1.0炭酸水素アン
モニウム 4.0エデト酸・4ナトリウ
ム 0.1精製水
82.9精製水に他の成分を加えて攪拌溶解させ
、透明な本第1剤を得た。First agent; (wt%) ammonium thioglycolate
12.0 (50% as thiochlorocholic acid) Ammonia water reagent special grade (28%), 1.0 Ammonium bicarbonate 4.0 Tetrasodium edetate 0.1 Purified water
82.9 Other ingredients were added to purified water and dissolved with stirring to obtain a transparent first agent.
第2剤; (重量%)、臭素酸ナ
トリウム 6.0第2リン酸す1
−リウム 0.1第1リン酸カリウム
0.3トロポエラスチン(乙ト窃禾)
1.0
精製水 92.6精製氷に
他の成分を加えて攪拌熔解させ、透明な本第2剤を得た
。2nd agent; (wt%), sodium bromate 6.0 secondary phosphoric acid 1
-Rium 0.1 monopotassium phosphate
0.3 Tropoelastin
1.0 Purified water 92.6 Other ingredients were added to purified ice and dissolved with stirring to obtain a transparent second agent.
例37と同様の方法により、ウェット時はくし通りの良
い滑らかなウェーブが得られた。乾燥させるとつややか
ではりのあるウェーブが得られた。By the same method as in Example 37, smooth waves with good combability were obtained when wet. When dried, shiny and firm waves were obtained.
lp「41− 以下の成分からパーマネントうエーブ剤を調製した。lp ``41- A permanent enamel agent was prepared from the following ingredients.
第1剤:例40と同じ
第2剤; (重量%)過酸
化水素水試薬特級(30%)7.0第2リン酸ナトリウ
ム 0.1第1リン酸カリウム
0.5エデト酸・2ナトリウム
0.1トロポエラスチン(7″Fm半)
0.5精製水 91.
8人の頭髪に本第1剤80mρを用いて、ロットでワイ
ンディング塗布してからキャップをかぶせ10分間放置
した。キャップを外して中間水洗を行い、余分の水分を
タオルで払き取った後、本第2剤を80mj!塗布し、
5分間放置した。次に、ロットを外し、水洗後タオルド
ライすると、つるつるとした滑らかな弾力のあるウェー
ブが得られた。ドライヤーで乾燥させるとつややかでは
りのあるウェーブが得られくし通りも良好であった。1st part: 2nd part same as Example 40; (wt%) hydrogen peroxide water reagent special grade (30%) 7.0 dibasic sodium phosphate 0.1 dibasic potassium phosphate
0.5 edetate, disodium
0.1 Tropoelastin (7″Fm and a half)
0.5 Purified water 91.
80 mρ of the first agent was applied to the hair of 8 people in a winding manner, and the hair was covered with a cap and left for 10 minutes. After removing the cap, washing with water, and wiping off excess water with a towel, apply 80mj of this second agent! Apply,
It was left for 5 minutes. Next, the lot was removed, washed with water, and then towel-dried to obtain smooth, elastic waves. When dried with a hair dryer, shiny and firm waves were obtained and the combability was good.
例−」(− 以下の成分から液状洗顔料を調製した。Example - "(- A liquid facial cleanser was prepared from the following ingredients.
(重量%)
(1)ラウリン酸カリ石鹸 5.0(2
)ミリスチン酸カリ石鹸 3.0(3)オレ
イン酸カリ石鹸 3,0(4) ヤシン
由脂肪酸シIタノールアマイト
5.0(5)プロピレングリコール 10.
0(6)トロポエラスチン(二v)+1氷)0.5(7
)精製水 73.5成分(1)
(2) (3) (7)の混合溶液の中に成分(4)
を添加し、次いで成分(6)を分散させた成分(5)を
添加して、加熱、混合溶解する。これを熱交換機にて冷
却して、液状洗顔料を得た。この液状洗顔料で洗顔した
時、使用中はなめらかな泡立ちであって、使用後はつっ
ばりが感じられず、優れた使用感であった。(Weight%) (1) Potassium lauric acid soap 5.0 (2
) Potassium myristate soap 3.0 (3) Potassium oleate soap 3.0 (4) Coconut fatty acid cytanol amite
5.0 (5) Propylene glycol 10.
0 (6) Tropoelastin (2 v) + 1 ice) 0.5 (7
) Purified water 73.5 ingredients (1)
Component (4) in the mixed solution of (2) (3) (7)
Then, component (5) in which component (6) is dispersed is added, and the mixture is heated, mixed and dissolved. This was cooled using a heat exchanger to obtain a liquid facial cleanser. When I washed my face with this liquid facial cleanser, it lathered smoothly during use, did not feel stiff after use, and had an excellent feeling of use.
例」づ− 以下の成分から固形石鹸を調製した。Examples A bar soap was prepared from the following ingredients.
(重量%)
(1)石鹸素地 98.6(2)
二酸化チタン 0.3(3)トロポ
エラスチン(ニワ)リー@矩)0.5(4)香料
1.0
成分(1)に成分(2) (3) (4)を添加して混
練し、イクリ 44
以下の成分から常法によりクレンジングフオームを調製
した。(Weight%) (1) Soap base 98.6 (2)
Titanium dioxide 0.3 (3) Tropoelastin (chicken) 0.5 (4) Fragrance
1.0 Components (2), (3), and (4) were added to component (1) and kneaded to prepare a cleansing foam from the following components in a conventional manner.
(重量%)
(1)ステアリン酸 10.0(2)
バルミチン酸 10.0(3)ミリス
チン酸 12.0(4)ラウリン酸
4.0(5)ピースワックス
1.0(6)苛性カリ
6.0(7)プロピレングリコール
1O30(8)ポリエチレングリコール400
5.0(9)トロポエラスチンにジトリ91)
0.5(lO)香 料 0.
5(11)精製水 36.5−
仇 45
以下の成分からヘアリンスを調製したところ、使用性の
優れた製品が得られた。(% by weight) (1) Stearic acid 10.0 (2)
Valmitic acid 10.0 (3) Myristic acid 12.0 (4) Lauric acid
4.0 (5) Peace wax
1.0 (6) Caustic potash
6.0(7) Propylene glycol
1O30(8) Polyethylene glycol 400
5.0 (9) Tropoelastin and Ditri91)
0.5 (lO) Fragrance 0.
5 (11) Purified water 36.5-
45 When a hair rinse was prepared from the following ingredients, a product with excellent usability was obtained.
(重量%)
ステア1ハtトリメデルアンモニウムクロライド
2.0モノオレイン酸ソル
ビタン 1.4ミネラルオイル
2.8セタノール
2.0ポリオキシエチレン(20)ソ)【1971
1才し了−F 0.3トロポエ
ラスチンにヮ)9*來) 1香料
適量
色素 適量
クエン酸 適 量水
全体を100とする足側−(下=
以下の成分から常法によりボディーシャンプーを8周製
した。(Weight %) Steer 1 hat trimedelammonium chloride
2.0 Sorbitan monooleate 1.4 Mineral oil
2.8 cetanol
2.0 polyoxyethylene (20) [1971
1 year old-F 0.3 Tropoelastin ヮ) 9*來) 1 Fragrance
Appropriate amount of pigment Appropriate amount of citric acid Appropriate amount of water
Feet side (lower = 8 rounds of body shampoo was prepared from the following ingredients by a conventional method, with the total number being 100).
ヤシ油カリ石鹸 10.0ヤシン
由j脂肪酸メチ;【タウリットナトリウム(30%>
10.0ラウl]イルジエタノールアマイ
ド 5.01.3−ブチレングリコール
3.0トロポエラスチンにワトリml) 0.
5精製水 65.0ところ
、使用性の優れた製品が得られた。Coconut oil potash soap 10.0 Coconut fatty acid methyl; [sodium taurite (30%)
10.0 laul]yldiethanolamide 5.01.3-Butylene glycol
3.0 Tropoelastin to Watori ml) 0.
5 Purified water 65.0 A product with excellent usability was obtained.
(重量%)
ラウリル硫酸ナトリウム 10千ノステアリ
ン 酸エチレングリコ−)ト2ポリオキシエチレン(7
5)ラノリン 0.25ヤシ油脂肪酸ジエタノール
アミド 5香料 適量
クエン酸 適 星塩化ナト
リウム 0.75トロポエラス
チン(シ看り切%> 0.8カ千オン化セルロ
ースエーテル 0.5水
全体を100とする足側−L8−
(重量%)
第ニリン酸カルシうム・2水和物 40.0グリセリ
ン 10.0ソルビツト
10.0カルネキシメチルセルロー
スナトリウム
1.5ラウリル硫酸ナトリウム 1.5サ
ンカリン 0.1香料
1,0
トロポエラスチン(シ訃す市%) 0.1精
製水 残 部上記組成か
ら通常の製造法により本発明の練歯磨を得た。(% by weight) Sodium lauryl sulfate 10,000 nostearate ethylene glycolate 2 polyoxyethylene (7
5) Lanolin 0.25 Coconut oil fatty acid diethanolamide 5 Fragrance as appropriate Citric acid as appropriate Sodium chloride 0.75 Tropoelastin (% % > 0.8 Kathionized cellulose ether 0.5 Water
Foot side - L8 - (% by weight) Calcium diphosphate dihydrate 40.0 Glycerin 10.0 Sorbit
10.0 Calnexymethyl cellulose sodium
1.5 Sodium lauryl sulfate 1.5 Sankarin 0.1 Fragrance
1.0 Tropoelastin (%) 0.1 Purified water Balance The toothpaste of the present invention was obtained from the above composition by a conventional manufacturing method.
前記例48の組成からトロポエラスチンを除いた以外は
全て例48と同様にして比較用練歯磨を得た。A comparative toothpaste was obtained in the same manner as in Example 48 except that tropoelastin was removed from the composition of Example 48.
歯周疾患をもつ患者20名を、症状の程度が各グループ
で同じになる様に10名ずつの2グループに分けた。各
グループにそれぞれ本発明および比較用の練歯磨にて1
日3回3分間のブラッシングを14日間にわたって行わ
せた。この期間中は他の口腔用組成物の使用を禁1トシ
、ブラッシングの指導は特に行わなかった。Twenty patients with periodontal disease were divided into two groups of 10 patients each so that the severity of symptoms was the same in each group. Each group received 1 dose of the present invention and comparative toothpaste.
Brushing was performed for 3 minutes three times a day for 14 days. During this period, the use of other oral compositions was prohibited, and no particular instructions on brushing were given.
効果の評点は以下の基準で行った。The effectiveness was evaluated using the following criteria.
歯周疾患に対して顕著な効果が認められた :3歯周疾
患に対して明らかに効果が認められた:2歯周疾患に対
してわずかに効果が認められた:1歯周疾患に対して効
果が認められなかった :0成績を表一本に示すが表中
の数値は10名の平均値である。Significant effect on periodontal disease: 3. Clear effect on periodontal disease: 2. Slight effect on periodontal disease: 1. No effect was observed: 0 The results are shown in one table, but the numbers in the table are the average values of 10 people.
表−手
本発明の練歯磨 比較用の練歯磨
評点 1.8 0.7表−4か
ら明らかなようにトロポエラスチンを0、1%配合した
本発明の練歯磨は比較用練歯磨よりも歯周疾患に対して
効果があった。Table-1 Toothpaste of the present invention Comparative toothpaste rating 1.8 0.7 As is clear from Table 4, the toothpaste of the present invention containing 0.1% tropoelastin was superior to the comparative toothpaste. It was effective against periodontal disease.
例」j 以下の成分から常法により練歯磨を調製した。Example"j A toothpaste was prepared from the following ingredients in a conventional manner.
(重V%)
無水ケイ酸 20.0ソル
ビツト 50.0カラギーナ
ン 0.5力;Iホキシメチルセ
BO−スナトリウム
1.0ラウリル硫酸す1−リウム 1
.8サツカリンナトリウム 0.08
パラオキシ安息香酸メチル 0.2香料
0.9
トロポエラスチン(if”*ネ)1.0精製水
残 部側−組
以下の成分から常法により口腔用パスタを調製した。(weight V%) silicic anhydride 20.0 sorbitol 50.0 carrageenan 0.5 strength; I phoxymethylsebo-sodium
1.0 1-lium lauryl sulfate 1
.. 8 Saccharin sodium 0.08
Methyl paraoxybenzoate 0.2 fragrance
0.9 Tropoelastin (if”*ne) 1.0 Purified water
Residue side - Pasta for oral cavity was prepared from the following ingredients by a conventional method.
(重量%)
ワセリン 10.0プロピレ
ングリコール 7.0ステアリルアルコ
ール 10.0ポリエチレングリコール1
500 30.0ヒノキチオール
0.1マウスE G F
O,001ppmトロポエラスチンにソトリ切?)
5.0ポリエチレングリコール400
残 部側−ト七
以下の成分から常法によりマウスウォッシュを調製した
。(% by weight) Vaseline 10.0 Propylene glycol 7.0 Stearyl alcohol 10.0 Polyethylene glycol 1
500 30.0 Hinokitiol
0.1 Mouse E G F
O,001ppm tropoelastin cut off? )
5.0 polyethylene glycol 400
A mouthwash was prepared from the remaining ingredients listed below in a conventional manner.
(重量%)
エチルアルコール 10.0サツカリ
ンナトリウム 0.05香料
0.8
ポリオキシエチレン(20モ;岬)ソ)岬ビタンラウリ
ン酸エステル 1.0トロポエラスチン(v
)1泉2 1.0精製水
残 部ljJユ
以下の成分から常法により口中清涼剤(スプレータイプ
)を調製した。(Weight%) Ethyl alcohol 10.0 Saccharin sodium 0.05 Fragrance
0.8 Polyoxyethylene (20 mo; Misaki) Misaki bitan laurate 1.0 Tropoelastin (v
) 1 spring 2 1.0 purified water
A mouth freshener (spray type) was prepared by a conventional method from the remaining ingredients below.
(重量%)
エチルアルコール 40.0サンカリ
ンナトリウム 0.1ソルビツト
10.0香料 1
.0
ポリオキシエチレン(60モ+L) 硬化 ヒマジン
由0.7塩酸クロルヘキシジン 0.0
5トロポエラスチン(9)書Q) 0・1精
製水 残 部側53
以下の成分から常法によりチューインガムを調製した。(Weight%) Ethyl alcohol 40.0 Sankarin sodium 0.1 Sorbit
10.0 Fragrance 1
.. 0 Polyoxyethylene (60 mo+L) Cured Himazine-derived 0.7 Chlorhexidine hydrochloride 0.0
5 Tropoelastin (9) Book Q) 0.1 Purified water Remainder side 53 Chewing gum was prepared from the following ingredients by a conventional method.
(重量%)
ガムヘース 25゜0炭酸カル
シウム 2.0香料
1.0
銅クロロフィル 0・05トロポ
エラスチンCシツトリ會ネン 0.1ソルビツト
粉末 残 部(Weight%) Gumhose 25゜0 Calcium carbonate 2.0 Fragrance
1.0 Copper chlorophyll 0.05 Tropoelastin C citrate 0.1 Sorbit powder Balance
第1図はニワトリのトロポエラスチンをコードするcD
NA断片の塩基配列及びそれから想定されるアミノ酸配
列を示す。
第2図は大腸菌発現ベクターの作製を示す流れ図である
。Figure 1 shows the cD encoding chicken tropoelastin.
The base sequence of the NA fragment and the amino acid sequence assumed from it are shown. FIG. 2 is a flowchart showing the construction of an E. coli expression vector.
Claims (1)
ツジ、ニワトリまたはマウス由来のトロポエラスチンを
コードする伝令RNAに対するcDNAを組込んだ発現
ベクターにより形質転換した大腸菌、枯草菌または酵母
によって生産されたトロポエラスチンである特許請求の
範囲第1項記載の皮膚外用剤。[Claims] 1. A skin external preparation containing tropoelastin. 2. The above-mentioned tropoelastin is produced by Escherichia coli, Bacillus subtilis, or yeast transformed with an expression vector incorporating a cDNA for a messenger RNA encoding tropoelastin derived from human, bovine, pig, sheep, chicken, or mouse. The skin external preparation according to claim 1, which is tropoelastin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61160189A JPS6314707A (en) | 1986-07-08 | 1986-07-08 | External preparation for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61160189A JPS6314707A (en) | 1986-07-08 | 1986-07-08 | External preparation for skin |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6314707A true JPS6314707A (en) | 1988-01-21 |
Family
ID=15709745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61160189A Pending JPS6314707A (en) | 1986-07-08 | 1986-07-08 | External preparation for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6314707A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63254180A (en) * | 1987-04-09 | 1988-10-20 | Kobayashi Kooc:Kk | Antioxidant composition |
JPH0429919A (en) * | 1990-05-25 | 1992-01-31 | Sunstar Inc | Moisture-retaining cosmetic |
US5726040A (en) * | 1993-11-10 | 1998-03-10 | Ensley; Burt D. | Cosmetic compositions including tropoelastin isomorphs |
WO1999045894A3 (en) * | 1998-03-09 | 1999-10-21 | Burt D Ensley | Cosmetic compositions |
US8227139B2 (en) | 2003-08-14 | 2012-07-24 | Asahi Glass Company, Limited | Polymer electrolyte fuel cell, electrolyte material therefore and method for its production |
-
1986
- 1986-07-08 JP JP61160189A patent/JPS6314707A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63254180A (en) * | 1987-04-09 | 1988-10-20 | Kobayashi Kooc:Kk | Antioxidant composition |
JPH0781139B2 (en) * | 1987-04-09 | 1995-08-30 | 株式会社コーセー | Antioxidant composition |
JPH0429919A (en) * | 1990-05-25 | 1992-01-31 | Sunstar Inc | Moisture-retaining cosmetic |
US5726040A (en) * | 1993-11-10 | 1998-03-10 | Ensley; Burt D. | Cosmetic compositions including tropoelastin isomorphs |
US6451326B2 (en) * | 1996-05-02 | 2002-09-17 | Burt D. Ensley | Cosmetic compositions |
WO1999045894A3 (en) * | 1998-03-09 | 1999-10-21 | Burt D Ensley | Cosmetic compositions |
US8227139B2 (en) | 2003-08-14 | 2012-07-24 | Asahi Glass Company, Limited | Polymer electrolyte fuel cell, electrolyte material therefore and method for its production |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4573690B2 (en) | Cosmetic oil or skin external preparation oil, and cosmetic or skin external preparation | |
JP4815164B2 (en) | Moisturizer and cosmetic and skin external preparations containing the same | |
JP5143354B2 (en) | Oligomer ester and cosmetics and skin external preparations containing these | |
JP4589050B2 (en) | Diesters and oils, and cosmetics and skin external preparations | |
JP5107560B2 (en) | Cyclohexanedicarboxylic acid diester and cosmetic or skin external preparation containing the same | |
JPH09255526A (en) | Cosmetic for preventing aging | |
JP4815166B2 (en) | Oily base and cosmetics and skin external preparations containing the same | |
JP2003226609A (en) | Lanolin-analogous composition, and cosmetic and skin care preparation containing the same | |
JP2001269398A (en) | Skin basement membrane formation accelerator, artificial skin formation accelerator, and method of manufacturing for artificial skin | |
JPH1053510A (en) | Composition for external use | |
JPH11269061A (en) | Cosmetic or dermatologal composition containing at least one natural or recombinant arachnida silk protein or analogue | |
JP6894207B2 (en) | Tranexamic acid-containing cosmetics or topical skin preparations | |
JP2009035500A (en) | Cosmetic and external preparation for skin | |
WO2008041623A1 (en) | External preparation for skin and cleansing agent for skin | |
EP1166745B1 (en) | Cosmetics containing polysaccharide-sterol derivatives | |
WO2003026698A1 (en) | External preparation for the skin | |
JP2667959B2 (en) | Cosmetic, hygiene or dermatological composition | |
JPS6314707A (en) | External preparation for skin | |
JPH06107517A (en) | Extensin protein-containing cosmetic composition and drug composition | |
JP2019156726A (en) | Cosmetic containing sparingly soluble component | |
JP5530052B2 (en) | Skin cleanser | |
JP2002265314A (en) | Solid cosmetic | |
JPH0764704B2 (en) | Cosmetics | |
JP4111766B2 (en) | Skin preparation | |
JP7195989B2 (en) | Erythritan derivative and cosmetics containing the same |